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Abstract 
 
Atim Atte Enyenihi 
 
Tandem Mass Spectrometry of Biomolecules: Applications and New Methods 
(Under the direction of Gary L. Glish) 
 
In the work presented here, new methods are developed for quadrupole 
ion trap (QIT) tandem mass spectrometry (MS/MS) of proteins and peptides and 
existing MS/MS methods are applied to real world problems. MS/MS is an 
indispensible tool for structural characterization of molecules. In the most 
common MS/MS experiment, an ion of interest, the parent ion is isolated. The 
mass selected ion is then activated so that the ion dissociates to form product 
ions which are subsequently mass analyzed. Although a variety of ion activation 
and dissociation methods exist, most often provide limited sequence information 
for proteins and peptides. A new method called electron ionization dissociation 
(EID) has been developed. It involves reaction of singly and multiply charged 
analytes with high energy electrons. EID provides increased chemical information 
as compared to the existing methods. 
In proteomics, the large scale study of proteins and peptides, 
quantification of expressed proteins is an important factor. Stable isotope labeling 
is a common approach to quantitative MS proteomics. Isobaric tag for relative 
and absolute quantification (iTRAQ) is one of the most common stable isotope 
iv 
 
methods and is based on the covalent linkage of primary amines with tags of 
varying masses. Quantitative information using iTRAQ is obtained from the 
abundance of low mass reporter ions, m/z 114-117 for a 4-plex reagent, 
observed in MS/MS spectra. CID is the most commonly used ion activation 
method in MS/MS. However, conventional CID in a quadrupole ion trap mass 
spectrometer (QITMS) cannot trap product ions below a low-mass cut-off 
(LMCO) of ~ 25% of the parent ion mass-to-charge, thus iTRAQ reporter ions are 
not detected. This represents a significant limitation because the QITMS is the 
most commonly used instrument for proteomics research. Part of the work 
presented here is to develop methods for iTRAQ quantification using a QITMS. 
A part of the work presented here involves application of existing MS/MS 
methods to real world problems. Recombinant protein technology allows 
industries to produce large quantities of proteins with specific characteristics for a 
variety of applications. Edman degradation, the primary method used to validate 
the integrity of recombinantly expressed proteins, is time consuming. Here, 
electron capture dissociation (ECD) MS/MS was explored as an alternative 
approach to Edman degradation for high throughput characterization of 
recombinant proteins. Finally, collision induced dissociation (CID) MS/MS was 
used to identify class I major histocompatibility complex (MHC) presented 
peptides on leukemia for use as anti-cancer immune targets.   
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Chapter 1
Introduction to Tandem Mass Spectrometry 
  
1.1 Overview of Mass Spectrometry 
The purpose of this work is to develop new methods for tandem mass 
spectrometry of proteins and peptides and to apply existing methods to real world 
problems. Mass spectrometry (MS) is an outstanding analytical technique 
because of its unparalleled sensitivity, limit of detection, speed and diversity of 
applications.1, 2  Detection of compounds can be accomplished with minute 
quantities, as little as 10-15 g in chemically complex mixtures.3 MS is used to 
identify unknown compounds, to quantify known compounds, and to elucidate 
structure and chemical properties of molecules. 
A mass spectrometric experiment involves three basic steps: ionization, 
mass analysis and detection. In the ionization step gas phase charged particles 
are created in the source region of the mass spectrometer. The ions are then 
separated in space or time based on the mass-to-charge (m/z) ratios in the mass 
analysis step. Mass analyzers include quadrupoles, quadrupole ion traps (QIT), 
time-of-flight (TOF), electric and magnetic sector, Fourier transform ion cyclotron 
resonance (FTICR) and the orbitrap. They differ in performance, cost, and 
principles by which mass analysis is achieved. Finally, the detection step 
measures the quantity of ions of each mass-to-charge ratio produced.  
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1.2 Tandem Mass Spectrometry (MS/MS) 
Historically, electron ionization (EI) has been used to charge gas phase 
atoms or molecules limiting its use to gaseous or volatile compounds. In EI, 70 
eV electrons interact with analytes to produce a radical cation (molecular ion). 
This molecular ion usually undergoes extensive fragmentation to form product 
ions. The product ions are then used to structurally characterize the sample of 
interest.  
The introduction of Nobel-prize winning electrospray ionization (ESI)4  and 
matrix-assisted laser desorption ionization (MALDI)5  have extended mass 
spectrometry to the analysis of large, nonvolatile biomolecules such as proteins. 
Today MS is the method of choice for proteomics, study of the protein 
complement of a genome.6 ESI and MALDI are “soft” ionization methods i.e. ions 
of the molecular species are produced with little fragmentation. Structural 
elucidation is achieved by activating the molecular species to effect its 
dissociation and is referred to as tandem mass spectrometry (MS/MS).7, 8 
In the most common MS/MS experiment, parent ion scan, an ion of 
interest, the parent ion (mp
+) is isolated. The mass selected ion is then activated 
so that the ion dissociates to form product ions (mp
+) and a neutral, mn (Equation 
1.1). The product ions are subsequently mass analyzed. The neutral product is 
not detected because MS analyzes exclusively charged molecules  
nfp mmm +→
++
 
Multiple isolation and fragmentation events can be performed if more information 
is required. For example mf
+, the first generation product ion can be isolated, 
(Equation1.1) 
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activated and dissociated to form second generation product ions in an MS3 
experiment. This process can be repeated a number of times, resulting in a 
series of MSn spectra where 'n' represents the number of times the isolation - 
fragmentation cycle has been carried out. 
1.2.1 Tandem Mass Spectrometry of Proteins and Peptides 
 The analysis of proteins and peptides is the driving force behind 
development of new methods and instrumentation in mass spectrometry.4 
Dissociation of proteins in MS/MS mainly occurs along the peptide backbone. 
The cleavage of a bond on peptide backbone can occur in any of three types of 
bonds: Cα -C, C-N and N-Cα. The resulting product ions are named a, b, c and x, 
y, z according to the nomenclature proposed by Roepstorff and later modified by 
Biemann (Figure 1.1).5, 6 
 In the figure, a generic peptide backbone is shown. Amino acid residues 
are represented by R; n indicates the total number of amino acids contained in 
the peptide. For the peptide shown, charging is due to the addition of a proton. 
Breakage of any of the indicated bonds will results in an ion and a neutral 
product. If the charge is retained by the N terminal side, a, b, or c type product 
ions are formed. Conversely, x, y, z ions retain the charge on the C terminal side.  
1.2.2 Instrumentation 
There are two general types of mass spectrometers, ion trapping 
instruments and beam instruments.7 Both use electric and/or magnetic fields for 
mass analysis. In beam type analyzers ions leave the source in a beam and pass 
through the analyzing field to the detector.  Beam type instruments require a                                                      
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Figure 1.1 Peptide fragmentation nomenclature and observed product ions. 
Prime indicates that the observed ion is one Da heavier than expected from 
simple cleavage of the indicated bond. Radical product is indicated by a dot. 
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distinct mass analyzer for each MS step and are therefore tandem-in-space. The 
triple quadrupole (QqQ) MS is a common example of a beam instrument. In this 
design three linear quadrupoles are aligned in series. The first mass analyzer 
(Q1) is used to isolate the parent ion, a second (q2) is operated in rf only mode 
and is used for parent ion activation. Finally, the third quadrupole (Q3) is used for 
mass analysis of the product ions. MSn experiments cannot be readily performed 
using a tandem-in-space instrument because of design complexity. For example, 
to achieve MS3, two additional quadrupoles will be needed.7 One, for isolating the 
first generation product ion produced in MS2 and another to effect its 
dissociation. Additionally, ion loss is associated with each stage because the ions 
are transferred from one quadrupole to another resulting in poor efficiency. 
In the case of trapping instruments, ions are stored in a potential field 
where they can be manipulated and ejected on the basis of the mass-to-charge 
ratio. Trapping instruments are tandem-in-time which means that the various 
stages of MS are performed in a single mass analyzer. Consequently, MSn 
experiments can be readily performed. Also, 100% of product ions can be 
trapped and measured because ions are not physically transferred from one 
analyzer to another. Ion trapping instruments include the quadrupole ion trap 
(QITMS), Fourier transform in cyclotron resonance (FTICR) and the recently 
developed orbitrap mass spectrometer. The focus here will be on QITMS 
because they are used in this work. 
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1.2.2.1 Quadrupole Ion Trap Mass Spectrometer 
The quadrupole ion trap mass spectrometer (QITMS)8, 9  is one of the 
most sensitive mass spectrometers available. Its use has dramatically expanded 
over the decade primarily because of developments in how mass analysis is 
performed. The instrument is operationally and mechanically simpler than an 
FTICR. It is often the work horse of most laboratories because they are rugged, 
offers MSn capabilities and are of low cost. 
1.2.2.1.1 Three Dimensional QITMS 
The 3D trap, also called Paul trap,10 consists of three hyperbolic 
electrodes: two endcap electrodes and a ring electrode. Typically, ions enter and 
exit the QIT through the endcap electrodes.  Sandwiched between the endcaps 
is the ring electrode. Together, these electrodes constitute the trapping volume of 
the QITMS where ions are trapped, stored and manipulated. The endcap 
electrodes define the trapping volume in the axial dimension (z0) and the ring 
electrode in the radial dimension (r0) as shown in the cross sectional view (Figure 
1.2). Ions in the QITMS are trapped and stored by applying an ac voltage in the 
radio frequency range to the ring electrode while the endcap electrodes are at 
ground potential. Trapped ions have a three dimensional oscillatory motion,  
Lissajous figure. Ion trajectories in the QITMS can be described using the 
Mathieu parameters, qz and az. 
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Figure 1.2 Cut-away view of a three dimensional quadrupole ion trap electrodes  
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where m is the mass of the ion, e is its charge, r and z are the radial and axial 
trap dimensions, Ω is the ac radio frequency (rf), V is the amplitude of the rf drive 
potential and U is the dc potential. The combinations of qz and az values that 
result in both stable axial and radial trajectories are depicted in a Mathieu stability 
diagram. (Figure 1.3) Ions with a and q values that fall within the stability diagram 
are trapped. The QITMS is commonly operated with no dc voltage (U) which 
makes the az term equal to zero. Hence, the working points of ions lie along the 
az = 0 line. At qz values greater than 0.908 ion’s trajectory becomes unstable and 
is not trapped. Therefore, the mass-to-charge value corresponding to qz =0.908 
is the lowest mass-to-charge ion trapped and is referred to as the low mass cut-
off (LMCO). Mass analysis can be performed by linearly increasing the rf 
potential which increases the qz value to the instability point. This mode of 
operation is termed mass selective instability and is partly responsible for the 
widespread use of the QITMS. 
The QITMS is typically operated with 1 mTorr of helium gas. The use of a 
bath gas serves several purposes. The bath gas is used to dampen the kinetic 
energy of ions generated outside the QITMS and injected into the trapping 
volume. The resolution is increased because ions get cooled to the center of the  
trap which leads to effective ejection during mass analysis. The kinetic energy 
damping also reduces ion loss and improves the trapping efficiency for improved 
sensitivity.  
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 Figure 1.3 The Mathieu stability diagram for ions in a three dimensional 
quadrupole ion trap 
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1.2.2.1.2 Two Dimensional QITMS  
The linear ion trap (LIT),11 like the 3D QITMS, uses a radiofrequency 
quadrupolar field to trap ions, but the field is two dimensional. In an LIT, set of 
four rods in a parallel array confine ions radially and a static electrical potential 
on the end electrodes confine the ions axially. Because there is no trapping in the 
z dimension, the trapping parameters are given in Equation 1.3 where u 
represents the x or y dimension.  
 
 
 
 
 A bath gas is also employed as in the 3D QITMS. In general, the main 
advantage of LIT is that a larger number of ions relative to the QITMS can be 
stored in the physically larger space before reaching the space charge limit. This 
implies that space charge effect, which leads to mass shifts and poor resolution, 
is less of an issue. The LIT can be used for mass analysis or for ion storage, 
which makes it commonly used in hybrid instruments. 
1.2.3 Ion Activation and Dissociation 
 Ion activation involves increasing the parent ion’s internal energy to cause 
its dissociation. The minimum amount of internal energy that parent ions must 
have in order to dissociate is the critical energy of dissociation (ϵ0). A diagram 
illustrating the critical energy of dissociation is shown in Figure 1.4. On the 
potential energy surface, the solid line at the bottom of the well represents the 
ion’s internal energy before activation. The arrow drawn from this initial point to 
the dashed line (tangent to the barrier of dissociation) is the ϵ0. Hence, the critical  
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Figure 1.4 Two-dimensional energy diagram show
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energy of dissociation is a relative measurement, and not the same value as the 
absolute energy ions must have to dissociate 
 There are a variety of methods to activate and dissociate ions. Commonly 
used methods include: collision induced dissociation (CID), infrared multiphoton 
dissociation (IRMPD), surface induced dissociation (SID), electron capture 
dissociation (ECD), electron transfer dissociation (ETD) and electron ionization 
dissociation. CID, IRMPD, and ECD are used in this work and are described 
below. EID is a relatively new method and will be discussed in Chapter 4.  In SID 
the parent ion collides with a surface causing dissociation.12-15 
1.2.3.1 Collision Induced Dissociation (CID) 
CID16, 17 is the most commonly used ion activation method because of its 
ease of implementation and availability in almost all commercially available mass 
spectrometers. To achieve CID, the parent ion is collided with a target, an inert 
gas. As a result of the inelastic collision, a fraction of the ion’s kinetic energy is 
converted into internal energy. The energy is statistically randomized and when 
the critical energy of dissociation is reached the ion dissociates to form product 
ions. The maximum amount of kinetic energy that can be converted into internal 
energy during such a collision is the center of mass collision energy (Ecom). 
   
pn
n
labcom
mm
m
EE
+
=  
In the equation Elab is the ion’s kinetic energy in the laboratory frame of 
reference. The mass of the neutral gas and the parent ion are represented by mn 
and mp respectively.  
(Equation 1.4) 
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 In practice, two collision regimes (high energy and low energy) exist. High 
energy CID occurs in the keV ion kinetic energy range and can be achieved 
using electromagnetic or hybrid instruments. Low energy CID occurs in the range 
of 1 -100 eV and is the case with QITMS and quadrupoles. The collision regimes 
have implications for the type of product ions formed. At low energy, the ion’s 
excitation is vibrational in nature and many collisions are required to overcome 
the dissociation barrier. In the case of proteins and peptides, the amide bond 
often breaks to produce b and y product ions via low energy CID.  
1.2.3.2 Infrared Multiphoton Dissociation (IRMPD) 
IRMPD18-20 involves increasing the internal energy of ions through 
absorption of multiple infrared photons. As the parent ion absorbs IR irradiation, 
the internal energy increases and is redistributed over all degrees of freedom. 
This redistribution is the same as the one that occurs in low energy CID during 
multiple collision events. Because of the statistical internal energy distribution 
IRMPD and CID produce similar types of product ions. However, more extensive 
fragmentation is often observed in IRMPD versus CID. 
 In quadrupole ion traps, the use of a bath gas has implications for IRMPD. 
As internal energy is increased by multiple IR absorption, ions undergo collisions 
with the bath gas and consequently loose a fraction of the IR excitation. The 
competition between the rate of collisional cooling and IR absorption reduces the 
IRMPD efficiency in ion traps.21, 22 Efforts to circumvent this issue include 
reducing the bath gas pressure, adding chromophores to the analyte, heating the 
bath gas, and, focusing the laser.23 
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1.2.4 Electron capture dissociation (ECD) 
  The ideal ion dissociation method24 should fragment many bonds so that 
the structure can be uniquely identified, occur faster than intermolecular 
rearrangements (hence the products resemble the starting structure), and give 
reproducible and simple spectra to facilitate interpretation.  Of all the methods 
used for MS/MS activation ECD25 is the closest to this ideal.  ECD involves the 
capture of low kinetic energy free electron by a multiply charged cation to form an 
odd electron charge reduced species. The radical charge reduced species then 
dissociates to form product ions depicted in Equation 1.5.  
 
 
ECD is unique in its ability to fragment strong bonds while preserving the 
weak ones. In the case of proteins and peptides, ECD cleaves the amine (N-Cα) 
bond on the peptide backbone to form c′ and z• product ions. This is in contrast 
to the slow heating methods IRMPD and CID, where the amide bond breaks to 
form b and y ions. Additionally, ECD preserves labile post translational 
modifications such as phosphorylation and glycosylation which are often lost 
using the slow heating methods. Furthermore, disulfide bonds are preferentially 
cleaved in ECD while they are stable to the vibrational excitation techniques 
mentioned above. 
Although, not employed in this work, electron transfer dissociation is the 
ion - ion analog of ECD; i.e. radical anions instead of free electrons react with 
[ ] [ ]( ) productsnHMnHM nen →+→+
•+−−+ 1 (Equation 1.5) 
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cations to give product ions. Both are generally thought to occur via the same 
mechanism and hence the same product ions are observed.  
1.3 Summary 
This chapter has provided an introduction to tandem mass spectrometry 
which is used for structural elucidation of molecules. The instrumentation and 
theory of ion trap mass spectrometry used in this work has been given. Also, the 
existing methods for ion activation and dissociation in MS/MS experiments have 
been discussed. Finally, MS/MS of proteins and peptides, which constitutes a 
majority of this work, has been discussed. In the remaining chapters, new 
MS/MS methods are developed for different applications and the existing 
methods are applied to real world problems. 
In chapter 2 MS/MS methods are developed for protein quantification 
using the iTRAQ and ion trap mass spectrometry. Isobaric tag for relative and 
absolute quantification (iTRAQ) is a common method for MS based protein 
quantification. Quantification using iTRAQ is based on low mass tags (reporter 
ions) observed in MS/MS spectra. CID is the most commonly used ion activation 
method in MS/MS but conventional CID in a QITMS cannot trap product ions 
below a low-mass cut-off (LMCO) of ~ 25% of the parent ion mass-to-charge, 
thus iTRAQ reporter ions are not detected. This represents a significant limitation 
because the QITMS is the most commonly used instrument for proteomics 
research. In this chapter MS/MS methods are developed for iTRAQ quantification 
using a QITMS. 
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 In chapter 3, electron capture dissociation is used to analyze recombinant 
proteins expressed for therapeutic purposes and x-ray crystallography efforts. 
Recombinant protein technology allows large quantities of proteins to be 
produced for industrial purposes. Currently, Edman degradation, which can be 
tedious and time consuming, is used to characterize recombinantly expressed 
proteins. ECD is explored as an alternative approach for high throughput 
characterization of recombinant proteins. It is hypothesized that ECD will be a 
faster approach to quality assurance of expressed proteins. 
In chapter 4, a new MS/MS method called electron ionization dissociation 
(EID) is developed for proteomics. Although a variety of MS/MS methods exist, 
as discussed, there are limitations with each method. For example, ECD is only 
applicable to multiply charged analytes. Also, complete sequence coverage of 
proteins is often not observed using the existing methods. EID involves reaction 
of singly and multiply charged analytes with high energy electrons. It is 
hypothesized that EID would give more informative spectra because of the 
increased internal energy deposition as compared to existing electron based 
methods. 
 Chapter 5 is a real world application of MS/MS. CID is used to identify 
peptides presented by class I major histocompatibility complex molecules on 
leukemia cells. The identified peptides are evaluated for use as anti-cancer 
immune targets.   
Chapter 6 summarizes the work shown in prior chapters and provides 
ideas for future research.
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Chapter 2
Tandem Mass Spectrometry Methods for iTRAQ Quantification 
using Quadrupole Ion Trap Mass Spectrometry 
 
2.1 Introduction  
Mass spectrometry (MS) is the method of choice for proteomics because 
of its high sensitivity, high analysis speed, low detection limit and high though-put 
capability but the emphasis has largely been qualitative.1 Because the proteome 
is dynamic, MS based proteomics is changing to include the ability to measure 
protein expression levels in addition to its identification. Isobaric tags for relative 
and absolute quantification (iTRAQ)2 is one approach to quantitative proteomics 
using mass spectrometry. Relative quantification using iTRAQ is obtained from 
the abundance of low mass reporter ions observed in tandem mass spectra.  
Collision induced dissociation (CID)3-6 is the most commonly used 
activation method for tandem mass spectrometry (MS/MS). However, 
conventional CID in a quadrupole ion trap mass spectrometer (QITMS) cannot 
trap product ions below a low mass cut-off (LMCO) of ~ 25% of the parent ion 
mass-to-charge; thus iTRAQ reporter ions are not detected. This represents a 
significant limitation because QITMS is the most commonly used instrument for 
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proteomics. The focus of this chapter is to develop methods for iTRAQ 
quantification using quadrupole ion trap mass spectrometry.  
2.1.1 Quantitative Proteomics 
In discovering biological markers that indicate cancer, tumors, or other 
diseases, it is often the quantity of proteins or the change in this quantity that is 
important.12 Therefore, quantitative information of expressed proteins constitutes 
a key step to a full understanding of disease processes. Furthermore, 
quantitative information of protein expression is pertinent for bioinformatics 
modeling of cellular processes such as pathways, cell maturation and 
metabolism. Additionally, proteins are continually synthesized and degraded to 
carry out cellular functions.13 
MS based methods for protein quantification can be divided into two 
categories: methods that employ stable isotopes as protein labels and those that 
do not. Stable isotopic labeling is accomplished either metabolically or 
chemically.  Metabolic labeling methods incorporate labels into proteins in vivo 
through food as the name implies. In a popular example called stable isotope 
labeling with amino acids in cell culture (SILAC)14 two cell populations are grown 
in culture media that are identical except that one contains a 'light' and the other 
a 'heavy' form of a particular amino acid (e.g. 12C and 13C labeled L-lysine, 
respectively). As the cells grow they incorporate the heavy isotope into the 
protein. Proteins from both cell populations are then combined and analyzed 
together using a mass spectrometer, which detects the mass shift. The ratio for 
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the peak intensity in the mass spectrum reflects the abundance ratio of the two 
proteins and is used for quantification. 
In contrast chemical labeling approaches use isotopically labeled tags to 
target reactive functionalities such as amines or sulfhydryl groups on proteins. 
The prototypical example, isotope coded affinity tags (ICAT),15 is composed of 
three parts: a reactive group that is cysteine directed, an isotopically coded 
linker, and a biotin tag for affinity purification. The protein of interest and a control 
are denatured, reduced and reacted with the light and heavy tag. Both are 
combined, digested and labeled peptides are isolated via an avidin column for 
mass spectrometric analysis. 
Label free quantification is based on ion signal and utilizes high 
performance instruments such as FTICR MS and Orbitrap MS for high quality 
data which facilitates extracting peptide signals in the first stage of mass 
spectrometry.  This decouples quantification from the identification step. Other 
methods like spectral counting do not require high quality data. This approach is 
based on the relative number of tandem mass spectra used to identify a 
particular protein called the spectral count. The spectral count has been shown to 
be linearly related to protein abundance.16 
2.1.2 Isobaric Tags for Relative and Absolute Quantification (iTRAQ) 
 iTRAQ2 is a chemical labeling approach similar to ICAT. It uses an N-
hydroxy succinimide ester to modify primary amino groups in proteins by linking a 
mass balance group (carbonyl) and a reporter group (N-methylpiperazine) to the 
N-terminus of proteolytic peptides. Due to the isobaric design of the reagents, 
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differentially labeled peptides appear at the same mass-to-charge in tandem 
mass spectra. One advantage of the iTRAQ approach as compared to ICAT and 
SILAC is the multiplexing capability. ICAT and SILAC can only do pair wise 
relative quantification. In the case of iTRAQ up to eight different samples can be 
analyzed simultaneously in a single MS/MS experiment. The iTRAQ reagents 
can be bought for a 4-plex or 8-plex experiment.  
In a 4-plex experiment, the reporter ions range in mass from 114 to 117 
Da. The balance moiety varies from 31 to 28 Da so that the mass of the tag 
remains constant at 145 Da. (Figure 2.1). This ensures that peptides, although 
labeled with any of the reporter groups, appear at the same mass-to-charge in 
the mass spectrum. Upon dissociation in an MS/MS experiment, the isotope 
coded reporter ions appear in the low mass region of the tandem mass spectra 
where there is low chemical noise. The relative abundance of the reporter ions is 
used for quantification. Absolute quantification can be obtained by spiking a 
known amount of the reagent into a sample. iTRAQ offers many advantages over 
ICAT. iTRAQ labeling is universal because all peptides contain the targeted 
primary amine group whereas only cysteine-containing peptides can be 
quantified using ICAT. Quantification using iTRAQ occurs in MS2, which adds to 
the specificity of the experiment. However, quantification on the MS/MS level has 
implications for ion trap CID and is discussed below.  
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a) 
 
 
 
 
 
 
 
 
b) 
 
 
 
 
 
 
 
Figure 2.1 a) Structure of the tag used in iTRAQTM  for a 4-plex reagent. b) 
Structure of the tag after reaction with a primary amine group on a peptide. 
Combination of stable isotopes used to achieve the isobaric tag is shown. 
Modified from Ross et. al. 
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2.1.3 Collision Induced Dissociation (CID) in a QITMS                                                                                                                             
CID in a QITMS is performed using resonance excitation.17 A 
supplementary radio frequency (rf) potential matching ion’s secular frequency is 
applied to the end cap electrodes. The resonant condition increases the kinetic 
energy of the ion.  A fraction of the kinetic energy is converted into internal 
energy via inelastic collisions with a helium bath gas until the critical energy of 
dissociation is reached and the ion dissociates to form product ions. Technically 
some excess energy above the critical energy is needed because of the kinetic 
shift.  A higher kinetic energy will result in greater internal energy gain, but it is 
possible that the supplementary voltage may increase the ion’s kinetic energy so 
much that the ion is ejected from the trap before it can dissociate.  The amplitude 
of the supplementary rf potential and the activation qz of the ion must be carefully 
selected to achieve a sufficient kinetic energy and concomitant internal energy 
gain without ejection.  A high qz for activation, which is equivalent to a deep 
potential well, implies that ions can be excited to high kinetic energy without 
exceeding the trap boundaries. A low activation qz, shallow well, implies that ions 
may get ejected from the trapping field upon increased kinetic energy. 
 From the previous statements, it would seem that CID should be 
performed at a high qz, but Equation 2.1 demonstrates why this is not so.  
 
 
In the equation, the mass-to-charge and qz of the parent ion are represented by 
Mp and qp respectively. The lowest mass-to-charge ion trapped corresponds to a 
P
ej
P
LMCO M
q
q
M = (Equation 2.1) 
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qz value of 0.908 (qej), and is termed the low-mass cut-off (LMCO), MLMCO.  It can 
be seen from this equation that a high qz of activation also means that a greater 
number of product ions fall below the LMCO and are not detected. To obtain 
effective dissociation and trapping along with a large mass range, CID is often 
performed at qz = 0.25.
7 At this qz value product ions with mass-to-charge 27.5 % 
(~ 30 %) of the parent ion’s mass-to-charge are not stored; this is often called the 
“one-third rule” for quadrupole ion traps. Quantification using iTRAQ is not 
possible using conventional CID in a QITMS because the low mass-to-charge 
reporter ions used for quantification are not detected. Other techniques have 
been developed to do tandem mass spectrometry in a QITMS while 
circumventing the LMCO issue. These methods include thermally assisted CID 
(TA-CID), high amplitude short time excitation (HASTE) CID, and infrared 
multiphoton dissociation (IRMPD). 
2.1.4 Methods to Reduce the CID Low Mass Cut-off Limitation 
TA-CID is one method to reduce the LMCO limitation of conventional CID. 
The helium bath gas is heated to temperatures greater than 100°C. This allows 
ions to be thermally excited to higher internal energies before collisional 
activation is performed. Consequently, lower supplementary ac voltages (150-
500 mVp-p) can be used to effect dissociation making ion activation at low qz 
values possible. For example, activation can be done at qz = 0.1 which reduces 
the LMCO to approximately 10 % of the parent ion. 
HASTE CID is performed at the conventional qz value of 0.25. However, 
short activation times (< 3 ms) and consequently high amplitude excitation 
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voltages (> 1 VP-P) are employed to effect dissociation compared to the 30 ms 
and 200-1000 mVp-p used in conventional CID.  After the activation step the rf 
trapping voltage is quickly lowered to qz = 0.1 to trap the low mass product ions 
that are produced. 
To perform IRMPD a laser beam is directed through the center of the ion 
trap where ions are confined. This means that the parent ion and product ions 
formed are non-selectively irradiated. An advantage of the non-selective nature 
of IRMPD is that successive generations of ions are formed. Low mass ions such 
as immonium ions, which are characteristic of amino acid residues, are readily 
observed using IRMPD. It is expected that iTRAQ™ reporter ions should be 
observed in high abundance as well.   
IRMPD  differs from CID in that the absorption of multiple infrared photons 
causes the internal energy increase. The implication is that ions can be activated 
at a low qz value without causing ejection obviating the CID “one-third rule.” 
Collisional cooling, which is directly related to pressure and inversely related to 
temperature, competes with photo-excitation at the 1 mTorr operating pressure of 
the QITMS leading to poor fragmentation efficiency.18, 19 For this reason, IRMPD 
in QITMS is often done at low pressures. However, the reduced helium pressure 
leads to poor resolution and sensitivity. A practical way to decrease the 
collisional cooling effect while achieving optimum instrument performance is to 
focus the laser.20  A focused laser allows maximum overlap of the laser with the 
ion cloud for improved fragmentation and is therefore used in this work. 
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Finally, TA-IRMPD, like IRMPD, can circumvent the CID LMCO. As 
mentioned earlier, for dissociation to occur after ion activation using IRMPD, the 
rate of collisional and radiative cooling must be slower than the activation 
process.  While the radiative cooling rate is slow, collisional cooling rate may not 
be.  Because collisional cooling is inversely related to temperature heating the 
bath gas constitutes another means to reduce energy loss through collisions 
while using the 1 mTorr pressure ideal for sensitivity and resolution.21 
2.2 Experimental 
2.2.1 iTRAQ labelling 
Glu1-fibrinopeptide B, EGVNDNEEGFFSAR, 1570.6 Da was labeled with 
iTRAQ 114 and iTRAQ 117 reagents (Applied Biosystems) using standard 
procedure. Strong cation exchange (SCX) and reversed phase liquid 
chromatography (RPLC) were performed for sample purification. iTRAQ 
incorporation adds 144 Da to the peptide mass for a total mass of 1715 Da. All 
chemicals were obtained from Sigma Aldrich Chemical Co. and used without 
further purification. Samples containing 30 nmol peptide were dissolved in a 
30:70:0.1 % acetonitrile:water: trifluoroacetic acid mixture at a concentration of 
50 µM.  As a proof of principle, iTRAQ 114 and 117 labeled peptides were mixed 
in approximately 1:1, 1:2, 1:5 & 1:10 v/v ratios for relative quantification using 
peak height of triplicate measurements. The doubly charged peptide although 
labeled with the 114 or 117 tag appears at m/z 858 in the mass spectrum. Upon 
activation the reporter ions are generated in the product ion spectrum and used 
for relative quantification. 
29 
 
2.2.2 Instrumentation 
 Protonated peptides were generated using nano-ESI on a modified 
Finnigan ion trap mass spectrometer (Figure 2.2) controlled by ion catcher mass 
spectrometer software (ICMS).22  Ion activation using conventional CID was 
performed at qz = 0.25. Supplementary alternating current (ac) voltage 400-1000 
mVp-p at 30 ms activation time was used. To perform TA-CID the helium bath gas 
was heated to 160 °C using a Lesker 1000 W stab-in heater as previously 
described.7, 21 The parent ion was activated at a qz of 0.1 using 200-500 mVp-p 
supplementary ac voltage.  Parent ion activation using HASTE CID is at the 
conventional qz of 0.25 but a short 2 ms, activation time is used. Consequently 
high excitation voltages relative to conventional CID, 1-2 Vp-p, are needed to 
effect dissociation. After activation the qz is lowered to 0.1 in 10 µs to trap the low 
mass ions produced. Single frequency excitation waveforms for activation were 
built externally to the ICMS software using a program written in LabVIEW®.  
A 50 W Synrad CO2 laser (10.6 µm wavelength) triggered by a TTL pulse 
from the ITMS electronics is used for focused laser IRMPD and TA-IRMPD. The 
beam path is directed through a ZnSe lens with a focal length of 38.1 cm, and 3.2  
mm holes in the ring electrode. To align the laser the beam is translated axially 
until maximum dissociation is observed for a peptide.  IR irradiation was at qz = 
0.1 and 1 x 10-3 Torr helium bath gas pressure for ambient and elevated 
temperatures. Irradiation time for ambient temperature IRMPD was 10 ms and 6 
ms for TA-IRMPD. TA-IRMPD was performed at bath gas temperature of 85 °C.  
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Figure 2.2 Schematic of the modified Finnigan 3D ITMSTM experimental 
configuration. Laser beam is directed through the center of the trap via a ZnSe 
window and 3.2 mm holes on the ring electrode. The heater bulb is mounted 
beneath the trap for thermally assisted experiments 
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MS/MS efficiency (Equation 2.2) and conversion efficiency (Equation. 2.3) were 
used to compare all the methods studied.  
 
 
 
 
MS/MS efficiency is defined as the ratio of summed product ion abundance (Σ P) 
to the initial parent ion abundance before activation (Po). Conversion efficiency
23 
measures the effectiveness of a method to generate the iTRAQ reporter ions.  
2.3 Results and Discussion 
2.3.1 Collisional Activation 
In the case of iTRAQ labeled glu1-fibrinopeptide B the low-mass cut-off at 
the conventional qz value of 0.25 is calculated to be 236 Da using Equation 2.1.  
At this LMCO only ions with m/z 236 or greater are stored for mass analysis, 
therefore iTRAQ reporter ions were not detected (Figure 2.3). Upon activation 
using TA-CID and HASTE CID the iTRAQ signature reporter ions are observed 
at m/z 114 and 117 (Figure 2.4). The product ions formed by peptide backbone 
cleavages are labeled and can be used for protein identification. In the HASTE 
CID spectrum, an ion at m/z 70 (asparagine, aspartic acid or arginine related 
mass ion) which corresponds to a parent ion q value of ~ 0.074 is observed. This 
indicates that HASTE CID can lower the LMCO to 8 % compared to 28 % using 
conventional CID. 
abundance)ion parent  (Initial
abundanceReporter 
=conversionE
(Equation 2.3) 
(Equation 2.2) 
o
/
P
P
E MSMS
Σ
=
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Figure 2.3 Collision induced dissociation of iTRAQ labeled glu1-fibrinopeptide B 
in the 0 - 650 Da range. Reporter ions are not observed because of the CID low 
mass cut-off. 
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Figure 2.4 MS/MS spectra of iTRAQ labeled glu1-fibrinopeptide B in a 1:2 
114:117 mixture using a) TA-CID b) HASTE CID in a QITMS. Spectra shown for 
low mass region (0 – 640 Da)  
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MS/MS efficiency is a measure of the extent of fragmentation achieved 
and the efficiency of collecting the product ions generated for mass analysis. 
Figure 2.5 is a plot of averaged triplicate measurement of MS/MS efficiency for 
all activation methods studied. MS/MS efficiency of TA-CID, although performed 
at a more shallow well depth, is comparable to that of conventional CID. The 
reason is that thermal activation causes ions to be excited to higher internal 
energies before collisional activation. As a result lower supplementary rf voltages 
can be used to effect dissociation and the product ions effectively trapped. 
HASTE CID resulted in the lowest MS/MS efficiency of the methods studied. The 
high amplitude excitation voltages needed may cause ion motion to exceed the 
boundaries of the trapping field causing ion ejection and consequently a low 
MS/MS efficiency. Another possibility, although unlikely, is that the parent ion 
may dissociate to small mass-to-charge product ions so that they are not 
detected even with the improved LMCO. 
 Conversion efficiency measures the effectiveness of a method to generate 
the reporter ions. TA-CID and HASTE CID both gave conversion efficiencies of ~ 
2 % as seen in Figure 2.6. One explanation for the low yield is that dissociation 
using CID is mostly a competitive process therefore many fragmentation 
pathways can be accessed as evident by the high abundance of backbone 
cleavage ions in the spectra. No reporter ions were observed using conventional 
CID as expected. 
Relative quantification was performed by mixing the 117- and 114- 
labelled peptide at different volume ratios. Peak heights of triplicate  
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Figure 2.5 MS/MS efficiency vs. ion activation method. Error bars are standard 
deviation of triplicate measurement.   
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Figure 2.6 Plot of conversion efficiency vs. activation method. Error bars are 
standard deviation of triplicate measurement 
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measurements were averaged and the relative standard deviation was calculated 
as shown in Table 2.1. TA-CID and HASTE CID were relatively accurate and 
precise up to 1:5 of the 114:117 labels.  Inaccurate quantification for the 1:10 
ratio is likely due to the low conversion efficiency observed.  
In the typical iTRAQ experiment proteins are digested, labeled, and 
pooled together for liquid chromatographic separation. This approach ensures 
that sample preparation is the same for each labeled peptide.  For the results 
shown in Table 2.1, the iTRAQ 114 and 117 samples were labeled and purified 
separately and then mixed together in various ratios. The separate sample 
handling introduces errors in peptide quantity, which would affect the accuracy of 
the measurements.  
2.3.2 Infrared Multiphoton Dissociation 
The balance between the LMCO and potential well depth is less important 
for IRMPD than CID because absorption of IR photons rather than increased 
kinetic energy effects dissociation. Therefore, a low qz value can be used for 
activation and low mass products ions effectively trapped and detected. Figure 
2.7 is a focused laser IRMPD spectrum of iTRAQ 114-labelled glu1 - 
fibrinopeptide B.  iTRAQ reporter ions are observed in high abundance relative to 
other product ions, for example, backbone cleavage ions. MS/MS efficiency was 
approximately 100 % for triplicate measurements (Figure 2.5). Conversion 
efficiency was ~20 % (Figure 2.6), which means that approximately one fifth of 
the initial parent ion formed the iTRAQ reporter ions.  A consequence of the 
improved conversion efficiency is accurate quantification for a greater range of  
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Table 2.1 iTRAQ quantification using TA-CID, HASTE CID, focused laser IRMPD 
and focused laser TA-IRMPD at various 114:117 v:v ratios. Results are an 
average of triplicate measurements of reporter ion abundances. RSD is the 
relative standard deviation 
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concentrations.  In the relative quantification study IRMPD gave a linear 
response for all ratios (Table 2.1). 
Due to thermal activation prior to IR absorption shorter activation times are 
used for TA-IRMPD compared to ambient temperature IRMPD. In Figure 2.7b, 
extensive fragmentation is observed for 6 ms TA-IRMPD of iTRAQ 114-labelled 
glu1-fibrinopeptide B. Abundant iTRAQ reporter ions signal is detected; 
consequently relatively low product ions abundance was observed. TA-IRMPD 
gave higher conversion efficiency than IRMPD performed at ambient temperature 
(Figure 2.6). A reason could be consecutive fragmentation due to increased 
internal energy deposition. The greater conversion efficiency relative to IRMPD 
did not improve the accuracy of quantification. Increased noise level with thermal 
assistance is a likely cause. MS/MS efficiency of TA-IRMPD was slightly lower 
than IRMPD at ambient temperature. This could be due to consecutive 
fragmentation which causes larger product ions to further fragment to product 
ions small enough to fall below the IRMPD LMCO.  
2.4 Conclusions 
iTRAQ quantification in a quadrupole ion trap using TA-CID and HASTE-
CID is reported. Results were compared to IRMPD and TA-IRMPD performed 
with a focused laser. As proof of principle iTRAQ 114 and 117 labeled peptide 
were mixed at ratios varying from 1:1 to 1:10 for relative quantification. Focused 
laser IRMPD produced much more abundant reporter ions, consequently, 
accurate and precise quantification was observed at all concentration ratios.  
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Figure 2.7 MS/MS spectra of iTRAQ 114 labeled glu1-fibrinopeptide B using 
focused laser a) IRMPD b) TA-IRMPD in a QITMS. 
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However, product ion abundances due to peptide backbone cleavages were 
lower as compared to TA-CID and HASTE CID. 
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Chapter 3
Top - Down Analysis of Recombinant Proteins in a 
Radiofrequency Linear Ion Trap 
 
3.1 Introduction 
A recombinant protein is one that has been genetically engineered.  In this 
process the DNA sequence of the protein of interest is inserted into the genome 
of an organism to encode the protein.  Recombinant protein technology1 (RPT) 
serves a variety of purposes. It allows industries to produce large quantities of 
proteins with specific characteristics. For example, RPT can be used to produce 
an enzyme with enhanced stability at high temperatures via site directed 
mutagenesis.  In medicine RPT can be used to manipulate metabolism in vivo 
which can be useful in treating diseases like diabetes. In chapter 4, electron 
capture dissociation is used to analyze recombinant proteins expressed for 
therapeutic purposes and x-ray crystallography efforts. Recombinant protein 
technology allows large quantities of proteins to be produced for industrial 
purposes. Currently, Edman degradation, which is time consuming, is used to 
characterize recombinantly expressed proteins. ECD is explored as an 
alternative approach for high throughput characterization of recombinant 
proteins.  
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3.1.1 Mass Spectrometry Based Proteomics 
Protein identification using mass spectrometry uses two approaches: 
bottom-up and top-down. In the bottom up approach2 protein of interest is 
proteolytically digested, using an enzyme of known specificity such as trypsin 
which cleaves C-terminal to lysine and arginine residues, to form peptides. The 
peptide masses are then compared to that of a genome or protein database to 
determine its identity. This is called peptide mass fingerprinting (PMF). 
Alternatively, the proteolytic peptides are fragmented using tandem mass 
spectrometric methods (Section1.2.3) to form product ions that are searched 
against a database.  In bottom up proteomics complete sequence coverage is 
often not obtained hence site specific mutation and post translational 
modifications cannot be detected.  
Alternatively, in the top down2-6 approach intact proteins are ionized, 
dissociated, and mass analyzed without a proteolysis step. This offers the ability 
to fully characterize a protein because the intact mass is measured prior to 
fragmentation. In practice, analysis of large proteins is challenging because high 
resolving power and mass accuracy are necessary which limits its use to high 
performance instruments such as FT-ICR MS. Additionally, fragmentation of 
large proteins is often performed using electron capture dissociation (ECD).7 
ECD often provides extensive backbone fragmentation while preserving post 
translational modifications (PTMs) which makes it the method of choice for top 
down proteomics.  
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3.1.2 Electron Capture Dissociation (ECD) in a Radiofrequency 
Quadrupolar Field 
Prior to 2004, ECD could only be performed using Fourier transform ion 
cyclotron resonance (FT-ICR) mass spectrometers. FT-ICR MS uses long 
interaction time and static electromagnetic fields for ion trapping. These 
characteristics make it uniquely suited for ECD because electron capture cross 
section is small (10-15 m2) and electron capture is most efficient at low electron 
energy (< 1 eV).8 Researchers have sought to implement ECD on more 
commonly used instruments, Vachet, on the Paul trap9 and Baba on the Penning 
trap.10 These efforts were unsuccessful partly because the time varying electric 
field used to trap ions in these devices increases the electron kinetic energy 
which prevents efficient electron capture. In 2004, Baba reported on the 
successful implementation of ECD in a radiofrequency ion trap.11, 12 
The novel concept for the success of the instrument is the rf ECD cell. The 
cell consists of a linear ion trap (LIT) and a permanent magnet wrapped. Ions are 
confined radially (x,y dimension) by the linear radio-frequency (rf) quadrupole 
field and axially (z dimension) by static electric fields. Electrons are injected 
along the z axis where the rf field is zero thus, electron heating is avoided. The 
magnetic field, oriented parallel to the z axis, is used to confine electrons to the 
central axis of the LIT and aids in axial transmission of electrons through the 
ECD cell. A modified version of the instrument is used for the work presented 
here and in subsequent chapters. 
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3.2 Materials and Method 
3.2.1 Sample Preparation 
Recombinantly expressed and purified proteins, RAR-related orphan 
receptor (31 kDa), RAC-beta serine / threonine-protein kinase II (41 kDa), Polo-
like kinase I (38 kDa), farnesoid X receptor (27 kDa), and epidermal growth factor 
receptor (41 kDa) were supplied by Glaxo Smithkline, Research Triangle Park. 
Expressed proteins were desalted using a Poros 10 R2 column and a reversed 
phase gradient. An Agilent 1100 LC / MSD TOF MS was used for LC/MS 
experiments and fractions were collected. Protein samples were concentrated 
using a Thermo Speed-Vac and were reconstituted in 1:1 water : acetonitrile + 
0.2 % formic acid.  
3.2.2 Mass Spectrometry 
 Protein sample was introduced into a modified NanoFrontier linear ion trap 
time-of-flight (LIT/TOF) mass spectrometer (Figure 3.1) by direct infusion nano 
electrospray ionization (nESI).  A glass capillary sprayer of 2 - 5 µm tip was 
pulled and a potential of 1400 - 2000 V was applied to the sample via a metal 
wire inserted into the capillary. Intact protein ions produced in the source are 
accumulated in the first ion trap and sent to the rf-ECD cell without mass-to-
charge selection. A quadrupolar potential applied to the LIT rod array traps ions 
radially and dc potentials applied to the I and E wall electrodes, along with dc 
offset applied to the rods trap ions axially. 
In the ECD cell ions are irradiated with electrons generated from a 
tungsten filament. The electron beam is radially confined by the magnetic field  
  
Figure 3.1 Modified NanoFrontier linear ion trap time
spectrometer  
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which also aids in electron transmission though the ECD cell. After electron 
irradiation, the product ions formed are sent through the thermalizer cell, where 
ion kinetic energy distribution is reduced, to a reflectron TOF MS for mass 
analysis.  
3.2.3 Electron Energy Determination 
The kinetic energy of electrons is determined from the potential difference 
between the tungsten filament and the ECD LIT rods plus the difference in work 
function between the thoriated tungsten filament and the stainless steel rods of 
the LIT. The work function (Φ) of stainless steel is 4.4 eV13 but that of the 
thoriated tungsten is temperature dependent as shown in Equation 3.1.14  
Tx
4
109.265.2
−+=φ  
The approach used in this work to estimate the temperature (T) of 
tungsten is based on the fact that values for R/R300K as a function of temperature 
are available,15  where R is the resistance. R can be calculated from Ohm’s law, 
V= IR, because V and I are known experimental parameters. R300K can be 
determined by measuring the potential difference across the filament at room 
temperature. At 0.1 A the potential difference was measured to be 12.2 mV. 
From this value the R300K was calculated to be 0.122 Ω. R300K was also 
determined theoretically using Equation 3.2. 
  
In the equation R is the resistance, ρ the resistivity of tungsten at room 
temperature (5.65 µΩ cm),14 l the length of the filament (1.8 cm) and A its area. 
From the diameter of the filament which is known to be 0.11 mm, the area is 
(Equation 3. 2) 
(Equation 3. 1) 
A
l
R
*ρ
=
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calculated and hence the resistance. The value for R was determined to be 0.107 
Ω which is close to the experimentally determined value. With R/R300K known, the 
temperature can be determined and thus the work function. Given that the ECD 
offset (EO) is 19.5 V, the filament offset (FO) is 20 V and the reading on the 
power supply, V = 3.2 V and I = 1.30 A, the electron energy is calculated as 
followed: 
Energy = (EO – FO) + C 
C = Φss – ΦTh-W 
Energy = (19.5 -20) + [4.4 – (2.65 + 2.95x10-4T)] 
T = 3600 K for an R/R300K value of 20.18 i.e R =3.20 V/1.30 A & R300K = 0.122 Ω. 
Energy = 0.2 eV 
3.3 Results and Discussion 
3.3.1 Farnesoid X Receptor 
In molecular biology nuclear receptors (NRs) are a class of proteins 
responsible for regulating the expression of specific genes thereby controlling the 
development, homeostasis and metabolism of the organisms. NRs are classified 
as transcription factors because they can bind to DNA and regulate the 
expression of adjacent genes when a ligand is present. Farnesoid X receptor 
(FXR) is a member of the metabolic superfamily of nuclear receptors.16-18 It is 
activated by bile acids, steroid carboxylic acid molecules synthesized from 
cholesterol. Physiologically, FXR serves as a bile acid sensor in the liver and 
intestine. An excess of bile acids can be harmful to the liver and a deficiency may 
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cause an increase in the cholesterol level of which they are precursors, therefore, 
FXR is a target for clinical applications. 
  Recombinantly expressed FXR was purified using online reversed phase 
liquid chromatography. Figure 3.2a is the mass spectrum of the eluted protein 
and 3.2b is the deconvoluted spectrum. The deconvoluted experimental mass 
matches the theoretically calculated value from the sequence shown in Figure 
3.3. The isoform of FXR used here contains 472 amino acids but only the ligand 
binding domain (243-472) was expressed. Fractions were collected during the 
LC-MS experiment for further characterization using electron capture 
dissociation. Figure 3.4a is the direct infusion nano electrospray mass spectrum 
of FXR. In the conventional tandem mass spectrometric experiment the parent 
ion is isolated prior to activation and dissociation. For these large proteins, no 
parent ion was selected prior to electron irradiation because a significant 
decrease in signal was observed. In the case of FXR multiple charge states 
could be isolated with some ion loss. However, it was observed that ions with 
high mass-to-charge values were lost during transmission of the intact protein 
from the first linear ion trap into the electron irradiation cell (Figure 3.4b).  
The electron capture dissociation mass spectrum of FXR in the low mass 
region which is within the TOF resolving power is shown in Figure 3.4c. N-
terminal product ions were observed at the expected mass-to-charge confirming 
that the protein was expressed without modifications. The c6′ ion is not observed 
because ECD does not cleave the amine bond N-terminal to proline. Because of  
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a) 
 
 
 
 
 
 
 
 
 
 
Figure 3.2  a) Mass spectrum of purified recombinant Farnesoid X Receptor from 
online liquid chromatography mass spectrometry experiment b) econvoluted 
spectrum. 
 
b) 
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       250        260        270        280        290        300  
GSTELTPDQQ TLLHFIMDSY NKQRMPQEIT NKILKEEFSA EENFLILTEM ATNHVQVLVE  
 
       310        320        330        340        350        360  
FTKKLPGFQT LDHEDQIALL KGSAVEAMFL RSAEIFNKKL PSGHSDLLEE RIRNSGISDE  
 
       370        380        390        400        410        420  
YITPMFSFYK SIGELKMTQE EYALLTAIVI LSPDRQYIKD REAVEKLQEP LLDVLQKLCK  
 
       430        440        450        460        470  
IHQPENPQHF AELLGRLTEL RTFNHHHAEM LMSWRVNDHK FTPLLEEIWD VQ  
 
Figure 3.3 Expressed region of Farnesoid X Receptor (243 - 472). 
Residues 241- 242 are remnants from TEV (tobacco etch virus) cleavage. 
Residues 432 and 466 have been changed from cysteine to glutamic acid, Mr = 
27,013.86 Da 
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Figure 3.4 a) nano electrospray mass spectrum of intact farnesoid X receptor 
(FXR). b) Spectrum after transmission into the ECD cell. c) ECD spectrum FXR 
in the low mass region. 
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its cyclic structure fragmentation of the N-Cα bond to the left of proline requires 
that two bonds be broken and is not observed in ECD (Figure 3.5). 
3.3.2 Retinoic Acid Receptor (RAR) - Related Orphan Receptor (ROR) βeta 
The RAR-related orphan receptor β, like FXR, is a ligand - regulated 
nuclear receptor.19-21 It is activated by all-trans retinoic acid (ATRA). Retinoids 
play a key role in development and regulate gene expression through binding to 
the nuclear retinoic acid receptor. Although the physiological role of ROR-β is not  
completely known, hence the name orphan, it is highly expressed in neonatal 
cells and may play a role in the development of rod photoreceptors.  
ROR-β contains 459 amino acid residues but only the ligand binding domain was 
recombinantly expressed (Figure 3.6).  A 12 Da mass shift from theory was 
observed from the deconvoluted LC-MS spectrum of the recombinant protein 
(Figure 3.7b). Therefore, ECD of the expressed protein was performed to 
determine the cause of the modification. As in the case of FXR the intact protein 
was subjected to ECD without isolation of any particular charge state(s). The 
ECD spectrum of ROR-β in the low mass region is shown in Figure 3.8. 
Extensive fragmentation of the N-terminal end of the protein is observed (more 
so than FXR). Despite the extensive fragmentation, the modification could not be 
determined. The observed product ions match the theoretical mass-to charge 
values. It is possible that the modification occurs away from the N-terminus which 
precludes its identification. 
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Figure 3.5 Cyclic structure of proline for the peptide R1PR3   
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                             210        220        230        240  
           MKKHHHHHHLVPRGSPGITMT EIDRIAQNII KSHLETCQYT MEELHQLAWQ  
 
       250        260        270        280        290        300  
THTYEEIKAY QSKSREALWQ QCAIQITHAI QYVVEFAKRI TGFMELCQND QILLLKSGCL  
 
       310        320        330        340        350        360  
EVVLVRMCRA FNPLNNTVLF EGKYGGMQMF KALGSDDLVN EAFDFAKNLC SLQLTEEEIA  
 
       370        380        390        400        410        420  
LFSSAVLISP DRAWLIEPRK VQKLQEKIYF ALQHVIQKNH LDDETLAKLI AKIPTITAVC  
 
       430        440        450  
NLHGEKLQVF KQSHPEIVNT LFPPLYKELF NPDCATACK  
 
Figure 3.6 Expressed region of RAR-related orphan receptor β (205-459). 
Highlighted N-terminal sequences corresponds to His tag. In green, site selective 
mutagenesis of glycine 457 to alanine. Mr = 31041.35 Da. 
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Figure 3.7  a) Mass spectrum of purified recombinant RAR-related orphan 
receptor β from online liquid chromatography mass spectrometry experiment b) 
Deconvoluted spectrum 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.8 a) Electron capture dissociation spectrum of RAR
receptor β in the low mass region b) depiction of 
terminal region c) Product ions show no modification;
example 
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3.3.3 Epidermal Growth Factor Receptor (EGFR) 
Receptor kinases modulate a variety of cellular events such as 
differentiation, growth, metabolism and apoptosis. Their function is to transfer the 
phosphate group from adenosine triphosphate (ATP) to tyrosine residues on 
specific proteins. This post translational modification not only maintains cellular 
homeostasis but also allows for the regulation of various signaling pathways. 
Hence protein tyrosine kinases are targets for both basic research and drug 
discovery. EGFR is a member of transmembrane receptor tyrosine kinases to 
which EGF binds.22 Mutations and over expression of EGFR have been detected 
in cancers of the lung and breast among others which makes it an important 
therapeutic target. 
EGFR consists of 1210 amino acid residues. The catalytically functional 
region (678-1020) was recombinantly expressed (Figure 3.9). Deconvoluted LC-
MS spectrum revealed a 39 Da mass difference from theory Figure 3.10. ECD 
was performed to identify the observed modification. ECD of the intact protein 
produced a series of N-terminal product ions shifted by 42 Da from the expected 
value (Figure 3.11). Therefore, the 39 Da mass difference obtained from the 
deconvolution step was inaccurate. The 42 Da post translational modification can 
be assigned as acetylation but because c1′ ion nor its complementary z• ion is 
observed the site of the modification cannot be determined. In theory the target 
site could be the N-terminus or lysine residues but it is more likely that the N-
terminal alpha amine is where the acetyl group is placed because this type of 
modification is widespread among eukaryotes. 
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                  680        690        700        710        720  
       MKKGHHHHHHGTLR RLLQERELVE PLTPSGEAPN QALLRILKET EFKKIKVLGS  
 
       730        740        750        760        770        780  
GAFGTVYKGL WIPEGEKVKI PVAIKELREA TSPKANKEIL DEAYVMASVD NPHVCRLLGI  
 
       790        800        810        820        830        840  
CLTSTVQLIT QLMPFGCLLD YVREHKDNIG SQYLLNWCVQ IAKGMNYLED RRLVHRDLAA  
 
       850        860        870        880        890        900  
RNVLVKTPQH VKITDFGLAK LLGAEEKEYH AEGGKVPIKW MALESILHRI YTHQSDVWSY  
 
       910        920        930        940        950        960  
GVTVWELMTF GSKPYDGIPA SEISSILEKG ERLPQPPICT IDVYMIMVKC WMIDADSRPK  
 
       970        980        990       1000       1010       1020  
FRELIIEFSK MARDPQRYLV IQGDERMHLP SPTDSNFYRA LMDEEDMDDV VDADEYLIPQ   
 
Figure 3.9 Expressed region of epidermal growth factor receptor (678-1020). 
Highlighted N-terminal sequences correspond to His tag. Mr = 40,528.72 Da. 
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Figure 3.10 a) Mass spectrum of purified recombinant epidermal growth factor 
receptor from online liquid chromatography mass spectrometry experiment b) 
deconvoluted spectrum 
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Figure 3.11 a) Electron capture dissociation spectrum of epidermal growth factor 
receptor in the low mass region b) depiction of observed backbone cleavages in 
the N-terminal region c) Product ions reveal a 42 Da mass shift from theoretical; 
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deconvolution step was inaccurate which is why MS/MS is necessary. The 42 Da 
post translational modification can be assigned as acetylation but because c1′ ion 
nor its complementary z• ion is observed the site of the modification cannot be 
determined. In theory the target site could be the N-terminus or lysine residues 
but it is more likely that the N-terminal alpha amine is where the acetyl group is 
placed because this type of modification is widespread among eukaryotes. 
3.4 Conclusions 
Electron capture dissociation (ECD) often provides extensive backbone 
fragmentation while preserving post translational modifications (PTMs) which 
makes it the method of choice for top down proteomics. Reported here is the use 
of a hybrid linear ion trap time-of-flight mass spectrometer with electron capture 
dissociation (ECD) to characterize large recombinant proteins, specifically, intact 
mass measurement and N terminal protein sequence verification.   
 For the purposes of the work presented here, obtaining partial 
sequencing especially directed towards the N- or C-termini is sufficient for 
sequence verification since in the single-stage MS experiment the molar mass of 
the protein was established. Attempts at performing ECD on LC-time scale were 
not successful due to low protein signal. The low abundance is primarily due to 
the multiple charging associated with electrospray ionization. Ion molecule 
reaction to concentrate different charge states into one peak (i.e. peak parking)23 
should help resolve this issue 
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Chapter 4
Electron Ionization Dissociation in a Radiofrequency Linear Ion 
Trap 
4.1 Introduction 
 As discussed earlier, electron capture dissociation (ECD) results from the 
dissociative recombination of multiply charged polypeptide cations and low 
energy electrons (< 1 eV) to yield c′ and z• ions. At higher electron energy, 3-13 
eV, another energy regime termed hot ECD (HECD) exists.1 In this energy 
regime, the N-Cα peptide backbone bond is cleaved to form c′ and z• ions as in 
the case of ECD, but additionally, extensive secondary fragmentation is often 
observed due to increased energy deposition into the parent.  The excess energy 
deposition in HECD is due to electronic excitation prior to electron capture. 
HECD allows differentiation of isomeric leucine and isoleucine due to secondary 
fragmentation from z• ions.1-3 Radical z ions from leucine loose 43 Da but that of 
isoleucine loose 29 Da. 
 Although ECD and HECD have many characteristics of the ideal ion 
activation and dissociation method there are also shortcomings. Firstly, ECD and 
HECD do not cleave the amine bond N-terminal to proline. This is because 
fragmentation of the N-Cα bond to the left of proline requires that two bonds be 
broken and is often not observed. Secondly, and perhaps more importantly, ECD 
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and HECD are only applicable to multiply charged species. This limitation is 
because the capture of an electron by a singly charged molecule would result in 
a neutral species which is not detected in mass spectrometry. The recently 
introduced electron ionization dissociation (EID) allows fragmentation of singly 
charged analytes which makes it useful for the analysis of tryptic peptides. 
 Fragmentation of singly charged cations using electrons was first reported 
in 1979.4 Termed, electron impact excitation of ions from organics (EIEIO), 
substituted benzene radicals were fragmented at electron energies below the 
second ionization energy. In 2003, Zubarev reported dissociation of protonated 
peptides from MALDI with electron > 10 eV.5 O’Hair reported on electron induced 
dissociation of singly protonated aromatic amino acids, cysteine, di- and tri- 
peptides at electron energies above the second ionization threshold in 2007.6 In 
2009, Zubarev reported EID of singly and multiply charged protonated peptides 
at electron energies at least 10 eV greater than the second ionization energy.7 All 
the works above were performed using FT-ICR MS.  
Reported here is the use of a radio frequency linear ion trap mass 
spectrometer to study the analytical usefulness of EID for analysis of peptides 
and oligosaccharides. The hypothesis is that EID will give more informative 
spectra because of the increased parent ion internal energy as compared to ECD 
and HECD. The use of ion trap mass spectrometry allows unique opportunities, 
such as MSn capability, to study the EID process which is not readily feasible 
using an FT-ICR instrument. In this work, EID is used to mean electron ionization 
dissociation not electron induced dissociation because of the generic nature of 
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the later. Electron ionization dissociation is appropriate because the ionization 
process is unique to this method in comparison to HECD and ECD. 
4.2 Materials and Method 
4.2.1 Samples 
The peptides YGGFL (leucine enkephalin), FGGYL, YGWFL, YGPFL, 
YGVFL, YAGFL, YGAFL, YGLFL, YGGFM (methionine enkephalin), FLEEI, 
FLEEV, ALILTLVS, FLLVPLG, RSRHF, RVYIHPF (angiotensin III), DRVYIHPF 
(angiotensin II), DRVYIHPFHL (angiotensin III), YGGFLR, YGGFLRR, 
RPPGFSPF (des-Arg9-bradykinin), VGVRVR, RPPGFSPFR (bradykinin), 
RPKPQQFFGLM (substance P), RPKPQQFFGLMGKR (substance P GKR), 
pyroELYENKPRRPYIL (neurotensin), EGVNDNEEGFFSAR (glu1-fibrinopeptide 
B, LFTGHPEpSLER, LFpTGHPESLER, ALSGRApSPVPAPSSGLHAAVR, 
HEVSASpTQpSTPASSR, LNQSpSPDNVTDTK , 
GIGAVLKVLTTGLPALISWIKRKRQQ-NH2 (melittin) and the polysaccharides, 
maltotetraose, maltopentaose, maltohexaose were studied. 
4.2.2 Mass Spectrometry 
 Ions formed from direct infusion nano electrospray ionization (nESI) are 
accumulated in the first linear ion trap of the modified NanoFrontier linear ion trap 
time-of-flight (LIT/TOF) mass spectrometer (Figure 3.1). The accumulated ions 
can be isolated and subjected to CID in the first LIT before TOF mass analysis. 
Alternatively, isolated parent ion can be transmitted through the quadrupole 
bender and the ion guide into LIT II for electron irradiation. In this second LIT 
ECD, HECD or EID, which differ in implementation only by the electron kinetic 
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energy, can be performed. Electrons are generated using a thoriated tungsten 
filament and the energy is changed by varying the filament offset (dc bias relative 
to ground applied to the tungsten filament) or the ECD offset (dc potential on the 
LIT rod set) as discussed in 4.2.3. Electron energy for ECD was 0.2 eV, 10 eV for 
HECD and 30 eV for EID. Electron irradiation time of 25 ms was used and 70 % 
of the initial parent ion abundance was depleted for all experiments. Product ions 
formed by electron irradiation are directed back through the thermalizer LIT (LIT 
III) to the reflectron TOF mass analyzer. In the electron irradiation cell, the 
addition of a supplementary alternating current (ac) waveform allows ECD or EID 
product ion to be further isolated and activated using CID.  
 Molecular oxygen reaction is performed in the thermalizer cell using 
ambient O2 from nESI source. Under standard instrument operation, each pulse 
into LIT III is in turn pulsed onto the TOF for mass analysis. When performing O2 
reaction, a potential is applied to skimmer II to trap the ions. The trapping allows 
oxygen adducts to form prior to mass analysis. 
4.3 Results and Discussion 
4.3.1 Efficiency of Ion Electron Interaction 
 It is well known that the electron ionization cross section is highest at 70 
eV for most organic compounds.8 In the case of EID, no such measurement have 
been reported. Equation 4.1 was used to determine the efficiency of ion electron 
interaction k.  
tkI
o
KEAe
P
P −
=  
(Equation 4.1) 
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In the equation, P is the abundance (integrated peak area of all isotopes) of the 
parent ion, Po the initial parent ion abundance, KE the electron kinetic energy, I 
the electron current exiting the cell as measured on the ion guide, and t 
represents the electron irradiation time. The time was constant at 25 ms for all 
experiments. Figure 4.1 is a plot of efficiency as a function of the electron energy. 
The plot is a result of two separate experiments. In the first experiment, the 
electron energy was varied from 0 eV to 12 eV and the electron energy was 
varied from 11 eV to ~70 eV in the second experiment. Two experiments were 
required because more fragmentation is observed for EID as compared to ECD 
at any given experimental conditions. If the power supply voltage to the filament 
is too high then the parent ion would be completely depleted in the EID energy 
regime but if the voltage is too low then no fragmentation would be observed in 
the ECD region. For this reason two separate experiments were necessary. In 
the figure, three distinctive regions are observed and can be assigned to ECD, 
HECD and EID energy regimes. It is already known that ECD cross section is 
maximum at < 1eV in accordance with the result. For EID a maximum is 
observed at ~30 eV therefore this electron energy was used for all EID 
experiments unless otherwise stated. 
4.3.2 EID of Standard Protonated Peptides 
4.3.2.1 EID of [FLEEV+H]+ 
The EID spectrum of singly protonated peptide, [FLEEV+H]+ is shown in Figure 
4.2. An expected outcome in the reaction of peptides with high energy electron is 
ionization (Equation 4.2). Ionization occurs because the high energy electron 
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Figure 4.1 Efficiency of ion electron interaction as a function of electron energy 
using [substance P+2H]2+ 
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Figure 4.2 Electron ionization dissociation of [FLEEV+H]+ 
 
 
 
 
 
 
 
150 225 300 375 450 525 600 675
0
2500
5000
7500
10000
12500
15000
17500
z
4
•y
3
d
a4
d
a3
[M
+
H
]+
-7
3
 D
a
[M
+
H
]2
+
• -
9
9
 D
a
[M
+
H
]2
+
• -
4
5
 D
a
[M
+
H
]2
+
•
[M
+
H
]+
-4
3
 D
a
[M
+
H
]+
-4
5
 D
a
b
4
b
3
a
3 a
4
a
4
2+
b
2
a
2
[M+H]
+
x6
A
b
u
n
d
a
n
c
e
m/z
76 
 
passes sufficiently close to an orbiting electron of the parent ion to repel the 
electron out of the molecule.  
−−•+−+
+++→++ fastslowfast eeHMeHM
2
][][  
Chemically, the loss of an electron by a molecule amounts to its oxidation. An 
expected outcome of the interaction of a molecule with high energy electrons is 
ejection of an electron to form an oxidized species. In the spectrum of FLEEV, 
indeed, the oxidized species is observed, although at a relatively low abundance. 
Product ions due to cleavage of all peptide backbone bonds are also observed. 
Cleavage of the amide bond gives b2, b3, b4, and y3 ions; the z4• ion is due to 
cleavage of the N-Cα bond and cleavage of the Cα-C bond is responsible for a2, 
a3, a3•, a4, a4•, a4
2+ and a4
2+• ions.  Interestingly, the a3, and a4 ions lost 58 Da as a 
result of glutamic acid side chain cleavage to form the respective d-ions labeled 
da3 and da4. Here dan is used to represent side chain loss from even electron a 
ion as opposed to side chain loss from a• ion which is also possible. Losses from 
both the parent ion and the oxidized species are also observed in the spectrum. 
The parent ions lost 45 Da (COOH), 43 Da (•C3H7 from leucine) and 73 Da 
(CH2CH2COOH from glutamic acid); and the oxidized species lost 45 Da and 99  
Da (valine residue). The 45 Da loss observed from both species could originate 
either from the C-terminal carboxylic acid or from glutamic acid side chain.  
4.3.2.1.1 Electron Energy Dependence of Product Ions 
To determine the sources of product ions in the [FLEEV+H]+ EID spectrum, 
spectra were taken at various electron energies, 6 eV, 7 eV, 8 eV, 9 eV, 10 eV 
and 20 eV (Figure 4.3). Spectra were also taken at 40 eV, 50 eV, 60 eV and 70  
(Equation 4.2) 
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Figure 4.3 [FLEEV+H]+ product ion formation as a function of electron kinetic 
energy. 
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eV to determine the best electron energy for EID. At 6 eV a4, a4•, b3, b4 and y3 
ions appeared. At 7 eV, b2, a3, a3•, ions appear and a2 ion appears at 8 eV. At 9 
eV d3 and d4 ions appear. A d ion is due to amino acid side chain loss from a-
type product ions. The z4• ion was observed at 10 eV which suggests that 
ionization of the parent ion is possible at this electron energy. Doubly charged 
ions even electron a4
2+, a4
2+• and [M+H]2+• appeared at 20 eV. At 30 eV c′ ions 
appear but at low abundance. Above this electron enegy, no new product ions 
appear.  
Figure 4.4 is a plot of representative product ions as a function of electron 
energy. A majority of product ions reach maximum abundance at 20 eV and the 
abundance decreased at higher electron energy. It was observed that the 
abundance of the odd electron ion, a4•, decreased as a function of electron 
energy while the even electron a4 increased. By 50 eV no evidence of the radical 
species was observed. The result suggests that a mechanism exists where an 
ions are formed from an• ions. 
4.3.2.1.2 Sources of Product Ions in EID spectrum of [FLEEV+H]+ 
If a high kinetic energy electron is not captured then the induced excitation 
converts into vibrational energy, in which case the amide bond breaks and b and 
y ions are formed.4 The process is referred to as electron impact excitation of 
ions from organics (EIEIO) and explains the origin of b and y ions. For 
consistency the EIEIO process will be referred to as electron activated 
dissociation (EAD) in this work.  
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Figure 4.4 Product ion abundance as a function of electron kinetic energy for 
[FLEEV+H]+ .   
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Breakage of the Cα
-C peptide backbone bond results in a type product 
ions. The commonly believed origin of an ions in low energy CID is loss of carbon 
monoxide from b ions.9  The resulting an ion has an N=C bond on the peptide 
backbone with the charge on the nitrogen atom.9 In high energy CID, an ions can 
form from an• (an+1) after homolytic cleavage, as alluded to earlier. The 
mechanism involves elimination of a backbone amide hydrogen or an amino side 
chain β hydrogen atom from the radical species. Elimination of a side chain β-
hydrogen atom results in an ions with Cα=Cβ on the side chain of the residue,
 
which is an alternative structure to the one mentioned earlier.10 The an ion can 
further react to form dn ion
9, 10 and explains the formation of d3 and d4 ions in the 
spectrum. The observed a4
2+•, results from homolytic cleavage of the Cα-C bond 
of the oxidized species with both charges on the N-terminal side. The a4
2+• ion 
further reacts to form a4
2+ as discussed. 
In ECD, c′ and z• ions are formed from capture of a low energy electron by 
multiply charged parent ion. The resulting charge reduced species (CRS), a 
radical, then reacts to form c′ and z• ions via cleavage of the N-Cα peptide 
backbone bond as shown in Scheme 4.1. The prime indicates that the product 
ion is one Da heavier than expected from homolytic cleavage of the N-Cα bond. 
−++
+−−−−− sloweCOOHRHHCOHRH 212 )(  
COOHRHOHCHRH −•+=−−→ + 212 )(  
 c′ z• 
(Scheme 4.1) 
81 
 
In the case of singly charged peptides, capture of an electron would result in a 
neutral which is not detected in mass spectrometry, therefore, the z4• ion must 
originate from reaction of the oxidized species.  
4.3.2.2 EID of [YGAFL+H]+ 
The EID spectrum of singly protonated YGAFL is shown in Figure 4.5. 
H2O loss from the parent ion and 107 Da loss, which corresponds to CH2C6H4O 
+ H• from tyrosine, are observed. Singly charged a, b and y ions from EAD are 
also present in the spectrum. Also, y3-H2O, [M+H]
2+• and a very abundant singly 
charged ion at m/z 205.1 are observed. The origin of the ion at m/z 205.1 is not 
known. One possibility is rearrangement of the amino acid residues followed by 
cleavage of the N and C terminal moieties to form an internal fragment, GF which 
matches the observed mass-to-charge value. The GF internal fragment is 
observed in the EID spectrum of YAGFL; in this case the origin is clear. 
 Additionally, an abundant c3′ ion is also observed. The presence of c′ ion, 
same as that observed in the spectrum is unexpected. In ECD c′ ions result from 
a neutralized hydrogen upon electron capture as discussed. Such a mechanism 
cannot apply in this case therefore the origin of the c3′ must be different. One way 
to form the c′ ion from the oxidized species is by hydrogen abstraction through-
space or through-bond. Assuming that the proton is on the N terminus and the 
radical site is on tyrosine residue, the radical can abstract an hydrogen atom 
from the C-terminal carbonyl or from phenylalanine β carbon to form the c3′ ion. 
Tyrosine has lone pair electrons which makes it a feasible site for ionization. The 
resulting C-terminal fragment would be a diradical, z and not z•.  
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Figure 4.5 Electron ionization dissociation spectrum of [YGAFL+H]+  
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Other researchers have observed c′ ions in photodissociation of serine or 
threonine containing singly protonated peptides.10, 11 The hydroxyl hydrogen on 
the amino acid side chains is proposed to be transferred to the amide nitrogen to 
form c′ ions. Serine and threonine residues were thought to facilitate the c′ ion 
formation. It was observed here that the c3′ ion observed in EID spectrum of 
YGAFL was also present in every EID spectrum of the leucine enkephalin 
derivatives studied. Additionally, the ion was among the three most abundant 
product ions in the spectra. In the case of YGGFL, YGPFL, YGVFL and FGGYL 
the c3′ ion was the base peak. A c2′ ion in addition to the c3′ was observed in the 
case of YGWFL which suggests that the presence of aromatic amino acids may 
also facilitate formation of the ions.  
4.3.2.3 EID of [Melittin+3H]3+ 
The EID spectrum of [melittin+3H]3+ with an amidated C-terminus is shown in 
Figure 4.6. For larger polypeptides such as melittin ionization successfully 
competes with backbone cleavage so that backbone cleavage ions are negligible 
while oxidation predominates. In addition to the singly oxidized species, 
[M+3H]4+•, another peak, [M+3H]5+, corresponding to double oxidation of the 
parent ion is observed and is indicative of ejection of two electrons. The ejection 
of two electrons could occur simultaneously or sequentially and will be 
investigated. Surprisingly, the charge reduced species, [M+3H]2+•, is also present 
in the spectrum and indicates that low energy electrons are present. The possibe 
sources of the low energy electrons will be discussed.  
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Figure 4.6 Electron ionization dissociation spectrum of [melittin+3H]3+. Inserts are 
the doubly oxidized and the charge reduced species. 
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4.3.3 Comparison of EID, CID and ECD Fragmentation 
4.3.3.1 [ALILTLVS+H]+ 
 The CID spectrum of [ALILTLVS+H]+ is shown in Figure 4.7a.  A series of 
a5-a7, and y3-y6 ions are observed. Additionally, H2O loses from b5, b6, and b7 
ions are observed. The most abundant product ions are the b ion and the base 
peak corresponds to the b7 ion. The EID spectrum of the singly protonated 
peptide is shown in Figure 4.7b. The a5-a7, b3 – b7 , y3 – y5, and water loss peaks 
from ions observed in the CID spectrum are also present in the EID spectrum. 
Additionally, a6•, a7•, a7
2+•, a7
2+, b3, b7
2+ are observed. Other ions include: a 
series of x4 – x7 radical and even electron ions, x7
2+, z4• - z7•, c4′ and neutral 
losses from the oxidized species. Table 4.1 lists the observed backbone 
cleavage ions and their abundances. 
The mechanism by which the c4′ ion is likely formed has been reported 
and involves hydrogen transfer from the hydroxyl hydrogen on threonine to the 
backbone amide.10, 11 Neutral loss of 44 Da corresponds to CO2, that of 30 Da is 
attributed to formaldehyde from serine and 56 Da corresponds to (CH3)2C=CH2 
from leucine. It is obvious that the EID spectrum is much more informative than 
that of CID. The side chain losses are unique to specific amino acids and can be 
used to confirm their presence during peptide sequencing. A 100 % sequence 
coverage was obtained from the a/x product ions alone in EID but 87 % 
sequence coverage was obtained using all the ions observed in the CID 
spectrum. 
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Figure 4.7 MS/MS spectra of [ALILTLVS+H]+ a) collision induced dissociation b) 
electron ionization dissociation 
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Table 4.1 Product ions, observed mass-to-charge and abundances for electron 
ionization dissociation of [ALILTLVS+H]+ 
Product ion m/z observed Abundance 
a5         484.33 13991 
a6 597.41 17612 
a6•
 598.42 6660 
a7 696.47 6206 
a7• 697.48 4643 
a7
2+ 348.74 24707 
a7
2+• 349.24 1646 
b3 298.21 190721 
b4 411.27 99740 
b5 512.32 111577 
b6 625.4 78472 
b7 724.47 126115 
b7
2+ 362.73 17825 
c4′ 428.3 28412 
x4 445.21 12124 
x4• 446.22 3456 
x5 558.29 13533 
x5• 559.3 14386 
x6 671.36 3841 
x6• 672.38 1514 
x7 784.47 10285 
x7• 785.5 886 
x7
2+ 392.74 351645 
y3 318.19 10164 
y4 419.23 17035 
y5 532.31 9949 
z4• 403.22 30236 
z5• 516.29 50522 
z6• 629.37 5169 
z7• 742.45 3717 
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4.3.3.2 [RPKPQQFFGLM+2H]2+ 
 The CID spectrum of doubly protonated substance P is shown in Figure 
4.8a. The spectrum is dominated by the b7
2+ ion. Other backbone cleavage 
product ions are: a3, a7, a7
2+, a8, a8
2+, a10
2+, b2, b3, b5 – b10, b7
2+ - b10
2+, y2, y4 – y10 
and y8
2+. Complete sequence coverage is achieved from the b/y product ions 
alone; a ions are also present. The ECD spectrum is shown in Figure 4.8b, and 
consists of a series of c4′ – c10′ product ions which gave 70 % sequence 
coverage. Cleavage of the amide bond to form the c3′ ion is not expected in ECD 
as discussed in section 3.3.1.  
The EID spectrum of the same peptide is shown in Figure 4.9. The 
assigned backbone cleavage ions and their abundances are given in Table 4.2. 
Like in the ECD spectrum, a series of c4′ – c10′ ions are observed. Additionally, 
the c2′ ion (also present in HECD) is observed and may be indicative of increased 
internal energy. Other ions, c5′
2+ and c6′
2+, are from the reaction of the oxidized 
species. In comparison to CID only doubly charged doubly charged even and  
odd electron a ions are observed. Also, b10
3+ ion is observed and is due EAD of 
of the oxidized species.  Complete sequence coverage was obtained. In addition 
to the backbone cleavage ions, neutral losses from the oxidized species were 
also observed. The origin of the 13 Da loss ion is not known. Loss of 74 Da 
corresponds to CH2=CHSCH3 from methione. 92 Da loss is due to CH2C6H5 
(phenylalanine) + H•.  100 Da loss is due to •C4N3H10 from arginine and 130 Da 
is due to C9H8N from tryptophan. Finally, 148 Da loss is due to a combined loss  
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Figure 4.8 MS/MS spectra of [RPKPQQFFGLM+2H]2+ a) collision induced 
dissociation b) electron capture dissociation. 
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Figure 4.9a) Electron ionization dissociation spectrum of doubly protonated 
substance P, [RPKPQQFFGLM+2H]2+ b) Expansion of the neutral loss region 
from the oxidized radical ion. 
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Table 4.2 Backbone cleavage ions, observed mass-to-charge and abundances 
for electron ionization dissociation of [RPKPQQFFGLM+2H]2+. 
Product ion m/z observed Abundance 
a5
2+ 290.19 880 
a5
2+• 290.69 502 
a7
2+ 427.75 5352 
a8
2+ 501.28 3636 
a8
2+• 501.78 402 
a9
2+ 530.2911 1349 
a9
2+• 530.29 493 
b3 382.25 2075 
b6 735.42 452 
b6
2+ 368.20 843 
b8
2+ 515.28 2276 
b9
2+ 543.79 6627 
b10
2+ 600.33 2502 
b10
3+ 400.55 1851 
c2′ 271.18 2693 
c4′ 501.28 3636 
c5′ 624.39 1596 
c5′
2+ 312.7 1831 
c6′ 752.45 1309 
c6′
2+ 376.73 1438 
c7′ 899.50 467 
c8′ 1046.58 666 
c9′ 1103.61 674 
c9′ 552.30 1516 
c10′ 1216.71 252 
x9
2+ 561.26 619 
x10
2+• 610.30 1639 
y8 967.45 574 
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of tryptophan side chain and H2O. The observed neutral losses can be used, like 
immonium, ions to indicate the presence of specific amino acids.  
4.3.3.3 [RPKPQQFFGLM+3H]3+ 
 The CID spectrum of [substance P+3H]3+ is shown in Figure 4.10a. The 
spectrum is dominated by the b10
2+ ion. Other backbone cleavage ions, a10
2+, 
a10
3+
, b2, b3, b5, b6, b5
2+, b6
2+, b8
2+ - b10
2+, b8
3+ - b10
3+, y2 and y3 are observed but in 
a relatively low abundance. 70 % sequence coverage was obtained from the 
ions. The ECD spectrum of triply protonated substance P is shown in Figure 
4.10b. The most abundant peak is that of the CRS. Neutral losses from the CRS 
include 1 Da (H•), 17 Da (NH3) and 45 Da (COOH). A series of c4′ - c8′ ions, c2′ 
and c6′
2+ - c10′
2+ were observed. Also, z5• - z9• series of ions along with a6•, a8
2+•, 
a9
2+•, a10
2+• were present. Surprisingly, abundant b10
2+ ion was observed. Other b 
ions b8
2+, b9
2+, b10
3+ and y ions, y4, y5 were also present in a low abundance. A 
mechanism exists for the formation of y ions in ECD12 but the presence of b ions 
in ECD spectra is unexpected, although it has been reported.13, 14 One  
explanation is due to dissociation of the even electron H• loss species from the 
CRS.14   80 % sequence coverage was obtained from the ECD spectrum.  
The EID spectrum is shown in Figure 4.11. The sequence ions are listed 
in Table 4.3. The base peak corresponds to b10
2+. Also abundant are the CRS 
and the oxidized species. As in the ECD case, losses of 45 Da and 17 Da from 
the CRS are observed. Additionally, the oxidized species lost 56 Da from leucine 
and 74 Da from methionine. 90 % sequence coverage was obtained for this 
peptide. From these results it is evident that EID gives more product ions which  
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Figure 4.10 MS/MS spectra of [RPKPQQFFGLM+3H]3+ a) collision induced 
dissociation b) electron capture dissociation. 
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Figure 4.11 Electron ionization dissociation spectrum of [RPKPQQFFGLM+3H]3+. 
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Table 4.3 Backbone cleavage ions, observed mass-to-charge and abundances 
for electron ionization dissociation of [RPKPQQFFGLM+3H]3+. 
Product 
ions m/z observed Abundance 
a5
2+ 290.19 775 
a5
2+• 290.69 1574 
a7
2+ 427.75 3437 
a7
2+• 501.78 1440 
a7
3+ 285.50 1159 
a8
2+
 501.28 1989 
a8
2+• 501.78 1312 
a9
2+ 529.8 700 
a9
2+• 530.29 1119 
a10
2+ 586.33 1807 
a10
3+• 591.33 602 
a10
3+ 391.56 763 
b3  382.25 1108 
b5
2+ 305.15 1223 
b6
2+ 368.21 2589 
b7
2+ 444.24 7937 
b8
2+ 515.28 3979 
b8
3+ 345.68 2184 
b9
2+ 543.79 13231 
b9
3+ 362.87 1890 
b10
2+ 600.32 39518 
b10
3+ 400.55 6489 
c2′ 271.18 2845 
c4′ 501.28 1989 
c5′ 624.39 1800 
c5′
2+ 312.7 3575 
c6′ 752.44 1615 
c6′
2+ 376.73 8229 
c8′
2+ 523.79 5659 
c9′
2+ 552.30 14032 
c10′
2+ 608.84 3983 
x9
2+ 561.26 608 
x9
2+• 561.77 836 
z6•  726.33 836 
z9•  1079.53 392 
z9
2+• 543.79 13231 
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spectrum of doubly protonated bradykinin, [RPPGFSPFR+2H]2+, is shown in 
Figure 4.12a.  The EID+CID spectrum is shown in Figure 4.12b. It was observed 
results in better sequence coverage of peptides. Also, fragmentation is different 
as compared to ECD and CID. 
4.3.4 Simultaneous EID and CID (EID+CID) 
Formation of the oxidized species is often dominant in EID spectra. 
However, its presence is uninformative for sequencing purposes. In ECD 
spectra, the CRS is also often dominant relative to backbone cleavage ions. The 
non-dissociative electron capture is due to intact noncovalent interactions that 
prevent product ion separation after backbone cleavage. Collisions with bath gas, 
IR irradiation, or heat have been used to activate the charge reduced species so 
that the non covalent interactions are disrupted and product ions are observed. 
This method termed activated ion (AI) ECD is commonly used to improve 
sequence coverage and product ion abundance in ECD.15, 16  
To mimic such an experiment, collisional activation of the oxidized species 
was performed simultaneously with electron irradiation (EID+CID). The EID 
spectrum of doubly protonated bradykinin, [RPPGFSPFR+2H]2+, is shown in 
Figure 4.12a.  The EID+CID spectrum is shown in Figure 4.12b. It was observed 
that EID+CID of [bradykinin+2H]2+ resulted in no significant change in the 
number or abundance of product ions (Figure 4.13). Upon examination of 
individual product ions, the abundance of few  ions, y3
2+, b5
2+, b6
2+, c4′, a8
2+, a5
2+ 
and x8
2+•, increased while the abundance of others either decreased or were  
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Figure 4.12 a) Electron ionization dissociation spectrum of [RPPGFSPFR+2H]2+ 
b) simultaneous electron ionization dissociation and collision induced dissociation 
(EID+CID) of the oxidized species  
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Figure 4.13 Simultaneous electron ionization dissociation and collision induced 
dissociation (EID+CID) of [RPPGFSPFR+2H]2+ a) summed abundance of all 
backbone cleavage ions b) backbone cleavage ions whose abundance increased 
c) neutral losses from oxidized species  
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unchanged. Some neutral losses from the oxidized species, 30 Da, 44 Da, 17 Da 
increased but 18 Da loss was unaffected.  
The same experiment was performed for [substance P+2H]2+. In this case 
only the b10
2+ ion, of all backbone cleavage ions, showed increased abundance 
in the EID+CID experiment. The neutral losses from the oxidized species 44 Da, 
92 Da, 100 Da and 130 Da also increased, but the 13 Da loss and water loss 
ions decreased. Additionally, the combined 148 Da loss ion (130 Da and 18 Da) 
observed in EID was absent in the case of EID+CID.  
The results of the simultaneous EID and CID experiments imply that all 
product ions in EID spectra do not originate from the oxidized species. The 
results also suggests that intramolecular interactions may be lost upon ionization 
in which case supplemental activation would have no effect on product ion 
observation. Another reason for the observed difference in activation of the 
oxidized species vs. the charge reduced species may lie in the nature of the 
radical ions.  
4.3.5 Fragmentation of Hydrogen Abundant vs. Hydrogen Deficient 
Species 
The species formed upon electron capture is hydrogen abundant, i.e. it 
has an extra hydrogen atom relative to the charge. Conversely, the species 
formed upon interaction with high energy electron is hydrogen deficient i.e. it 
lacks a hydrogen atom relative to the fully protonated, even electron ion. Melittin 
with an amidated C terminus was used to study the structures of these species. 
[M+3H]4+• formed from EID of [M+3H]3+  was isolated  and collisionally activated.  
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The charge reduced species, [M+5H]4+• , from ECD of [M+5H]5+ was also isolated 
and collisionally activated.   
The EID/CID MS3 spectrum of [M+3H]4+• is dominated by water loss from 
doubly charged y8 ion at m/z 562.3 (Figure 4.14a). This dissociation channel is 
completely absent in the ECD/CID MS3 spectrum which makes it unique to the 
hydrogen deficient ion.  A molecular oxygen adduct ion is observed at m/z 719.9. 
Observed backbone cleavage ions include: b5, b6, b7, b13
2+, b17
2+, b18
2+, c7′, c9′, 
c18′
2+, x7
2+•
, x13
2+/x13
2+• and z7
2+•
.
  Also, a 29 Da loss (•CH2CH3 from isoleucine) 
from z7
2+• is observed. 
The ECD/CID MS3 spectrum of [M+5H]4+• is shown in Figure 4.14b. 
Backbone cleavage ions are a13
3+, b5, b6, b13
2+, c7′, c18′
2+, x7
2+•
, y13
2+
, y13
3+, y16
3+, 
y24
3+, z6
2+•
, z7
2+•, and z8
2+•. Additionally, 43 Da loss (•C3H7 from leucine) from z11
2+• 
and 29 Da loss (•CH2CH3 from isoleucine) from z7
2+• are present. These losses 
are important for distinguishing between isobaric isoleucine and leucine. Also, an 
abundant triply charged ion at m/z 527.3 is present. It is possibly due to a 43 Da 
loss from the y13
3+ ion. The ECD/CID MS3 and EID/CID MS3+ experiments 
confirm that the charge reduced and the oxidized radical ions are different. 
4.3.6 Oxidation Threshold Determination 
 The presence of the oxidized species in EID spectra is inconsequential for 
sequencing purposes as mentioned. However, it can be used to determine the 
threshold of oxidation of analytes i.e. the ionization energy essentially. In such an  
experiment, the electron energy is varied and the appearance of the oxidized 
species is monitored. There exists a region of linear increase in the abundance of  
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Figure 4.14 a) Electron capture dissociation collision induced dissociation MS3 of 
[Melittin+5H]4+• b) Electron ionization dissociation collision induced dissociation 
MS3 of [Melittin+3H]4+• 
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the oxidized species therefore a linear regression can be used to determine the 
threshold energy. An example using glu1-fibrinopeptide B is shown in Figure 
4.15. Bogdan and Zubarev have used the same approach to measure the 
ionization energy of several polypeptides.17 Here measurements are made for a 
larger number of peptides of varying charge states (Table 4.4).  
In general, the oxidation threshold of peptides increased with increasing 
charge state. Exceptions were [melittin+3H]3+, [DRVYIHPF+H]+, and 
[EGVNDNEEGFFSAR +2H]2+. The measured threshold for [melittin+3H]3+ was 
14.1 eV which is in the range of doubly protonated peptides. For 
[DRVYIHPF+H]+, the measured oxidation threshold of 14.5 eV is far larger than 
those of singly protonated peptides. Melittin, contains 26 amino acid residues 
and is therefore much larger than the peptides studied which could explain the 
result. However, it is not clear why angiotensin II and glu1-fibrinopeptide B 
deviate from the expected trend.  The oxidation threshold for 
[RPKPQQFFGLM+H]+, has been reported by Zubarev et. al. to be 10.3 ± 0.2 
eV17 which compares favorably to the measured value of 10.7 ± 0.5 obtained 
here. 
4.3.7 Fragmentation of Even vs. Odd Electron Ions 
4.3.7.1 [RPPGFSPFR +3H]3+  vs. [RPPGFSPFR+2H]3+• 
  To study the fragmentation even and odd electron ions, CID of [M+3H]3+ 
was performed and compared to that of [M+2H]3+• EID of the doubly charged 
peptide produce the oxidized species which was subsequently isolated and 
collisionally activated. The CID spectrum of even electron bradykinin is shown in  
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Figure 4.15a) Abundance [glu1 Fibrinopeptide B+2H]3+• vs. electron energy  b) 
The linear region is fitted to a line and the electron energy where where y = 0  
determines the threshold of ionization. 
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Table 4.4 Oxidation threshold (OT) measurements of standard protonated 
peptides. N indicates the number of trials. Standard deviation is from triplicate 
measurements. 
 
  
Peptide 
Charge 
state 
m/z OT STDEV N 
RPPGFSPFR 2 531 13.9 0.2 4 
 
3 354 15.2 0.1 4 
ENYENKPRRPYIL 2 837 15.0 0.1 4 
 
3 559 15.4 0.2 5 
DRVYIHPFHL 2 649 14.5 0.0 1 
 
3 433 15.7 0.2 4 
DRVYIHPF 1 1047 14.5 0.3 2 
 
2 524 14.7 0.4 3 
RVYIHPF 1 932 13.5 0.0 1 
 
2 466 13.7 0.3 4 
RPKPQQFFGLM 1 1349 10.3 0.2 2 
 
2 674 14.2 0.4 5 
 
3 450 15.2 0.1 4 
Melittin 3 950 14.1 0.5 4 
 
4 712 16.0 0.3 4 
 
5 570 16.3 0.2 3 
YGAFL 1 570 12.9 0.5 3 
YGGFC S-S Dimer 2 273 13.9 0.3 3 
YGGFM 1 574 12.5 0.4 3 
YGVFL 1 598 13.1 0.0 3 
YGWFL 1 685 12.9 0.2 3 
EGVNDNEEGFFSAR 2 786 16.1 0.3 4 
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Figure 4.16a. Water loss from the parent ion and b6
2+ are the most abundant 
product ions. Other ions include: a5
2+, a6
2+, b4 - b6, b5
2+, b7
2+, b8
2+, y3 - y5, y3
2+- 
y5
2+ and y7
2+. The EID/CID MS3 spectrum of [M+2H]3+• is shown in Figure 4.16b. 
The spectrum is similar to that of [M+3H]3+. Dehydration of the oxidized species 
and b6
2+ are also favored fragmentation channels. Other ions are: a5
2+, a8
2+/a8
2+•, 
b5, b5
2+/(b5-1)
2+, b6, y3/y3-1, y4/y4 -1, (y4-1)
2+, y7
2+/ (y7-1)
2+, c4′ and c5′. Additionally, 
loss of formaldehyde from the oxidized species is observed. The c′ ions and a8
2+• 
are only observed in the CID spectrum of the oxidized species and are therefore 
radical driven. Observance of a one Dalton mass difference can be attributed to 
the hydrogen deficient radical ion. 
In the EID+CID experiment (Figure 4.13) the b6
2+ ion showed the greatest 
increase in abundance which confirms its origin from the oxidized species. Other 
ions b5
2+, c4′, a8
2+, a5
2+ whose abundance increased in the EID+CID experiment 
are also observed in the EID/CID MS3 spectrum. However, y3
2+ and x6
2+ are not 
observed. Also, the water loss ion was unchanged in the EID+CID experiment 
although it represents a major fragmentation channel in the EID/CID MS3 
experiment. 
4.3.7.2 [RPKPQQFFGLM+3H]3+ vs. RPKPQQFFGLM+2H]3+• 
The same experiment was repeated for substance P (Figure 4.17). CID of 
[M+3H]3+ mostly produced b10
2+ and b9
2+ ions as discussed earlier. In contrast, 
the CID spectrum of [M+2H]3+• is dominated by loss of methionine side chain. 
The most abundant backbone cleavage ion is b10
2+ which was the only backbone 
cleavage ion with a significant increase in abundance in the EID+CID  
106 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.16 Fragmentation of even electron vs. odd electron bradykinin, 
RPPGFSPFR a) Collision induced dissociation of [M+3H]3+ b) Electron ionization 
dissociation collision induced dissociation (EID/CID) MS3 of [M+2H]3+•. 
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Figure 4.17 Fragmentation of even electron vs. odd electron substance P, 
RPKPQQFFGLM a) Collision induced dissociation of [M+3H]3+ b) Electron 
ionization dissociation collision induced dissociation (EID/CID) MS3 of [M+2H]3+•. 
 
200 300 400 500 600 700 800 900
0
200000
400000
600000
800000
1000000
1200000
b
9
2+
b
10
2+
A
b
u
n
d
a
n
c
e
m/z
200 300 400 500 600 700 800
0
10000
20000
30000
40000
50000
60000
70000
80000
[M+2H]
2+
-75Da
[M+2H]
3+•
-74Da
b
10
2+
/b
10
-1
2+
a
4
/a
4
•
b
8
2+
/b
8
2+
-1
b
9
2+
/b
9
2+
-1
[b
10
+H
2
O]
2+
[b
10
+H
2
O]
3+
b
10
3+
b
2
/b
2
-1
A
b
u
n
d
a
n
c
e
m/z
b) 
a) 
108 
 
experiment.  Other ions include: a4/a4•, a7
2+/a7
2+•, a8
2+, a9
2+•, a10
2+/a10
2+•, 
a10
3+/a10
3+•, b2/b2-1, b3/b3-1, b6
2+, b7
2+, b8
2+/(b8-1)
2+, b9
2+/(b9-1)
2+, (b10-1)
2+, b10
3+,  
c6′
2+, x9
2+, y2, y3. Additionally, a triply charged ion at m/z 406.55 and another 
doubly charged ion at m/z 609.33 are observed in high abundance.  These ions 
correspond to [b10+H2O]
3+ and [b10+H2O]
2+, respectively. Formation of [bn-1+H2O] 
ion has been reported and involves loss of the C terminal amino acid residue to 
give a product ion having a carboxyl group at the new C-terminus.18 Hydrogen 
bonding between the protonated side chain of a basic amino acid and the C 
terminal residue is the proposed formation mechanism of such an ion.18 From 
these experiments, it is clear that fragmentation of an even electron ion is 
different from that of an odd electron ion.  
4.3.8 Fragmenting Species in EID Spectra 
In ECD, product ions are typically formed exclusively from dissociation of 
the charge reduced species. In the case of CID product ions originate from 
dissociation of the parent ion. In EID, product ions could originate from several 
ions of the molecular species which include the parent ion, the oxidized species, 
the charge reduced species, and the doubly oxidized species. The doubly 
oxidized species is observed in EID spectra of [melittin+3H]3+. 
4.3.8.1 Doubly Oxidized Species 
Formation of the doubly oxidized species is due to ejection of two 
electrons from the parent ion. Ejection of two electrons could occur 
simultaneously or sequentially. In the case of [Melittin+3H]3+, sequential ejection 
means that an electron is first removed from the parent to form [M+3H]4+• and 
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another electron is subsequently ejected from the singly oxidized species to form 
the doubly oxidized species, [M+3H]5+. If it is a sequential event then ejection of 
the intermediate should result in depletion of the doubly oxidized peak.   
The EID spectrum of [melittin+3H]3+ prior to ejection is shown in Figure 
4.18.To investigate the origin of [M+3H]5+ the singly oxidized species, [M+3H]4+•, 
was resonantly ejected and the abundance of [M+3H]5+ was monitored (Figure 
4.19). [M+3H]4+• was resonantly excited until a 99 % reduction in the initial 
abundance was achieved. It was observed that the initial abundance of [M+3H]5+ 
decreased by 89 %. The result implies that the doubly oxidized peak originates 
predominantly from ejection of an electron from the singly oxidized species. The 
remaining 11 % is more likely due to ejection of the singly oxidized species 
occurring slower than formation of the doubly oxidized species. A 20 % decrease 
in abundance of the charge reduced species (CRS) was also observed which 
implies that a population of the CRS is due to double electron capture by the 
singly oxidized species. 
To further confirm the results the electron energy was varied and the 
abundance of the singly and doubly oxidized species were monitored (Figure 
4.20). It was observed that the doubly oxidized species formed only after an 
appreciable amount of the oxidized species had been produced which confirms 
the previous findings. 
 
  
  
 
 
Figure 4.18 Electron ionization dissociation spectrum of [melittin+3H]
resonant ejection of [M+3H]
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Figure 4.19 Electron ionization dissociation spectrum of [melittin+3H]
resonant ejection of the singly oxidized species [melittin+3H]
oxidized species, [melittin+3H]
formation from [melittin+3H]
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Figure 4.20 Plot of abundance [M+3H]4+• and [M+3H]5+ as a function of electron 
energy using [melittin+3H]3+. Error bars are standard deviation of triplicate 
measurement. 
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4.3.8.2 Charge Reduced Species 
As discussed earlier, the parent ion can dissociate via vibrational 
relaxation to form b and y ions (EAD). It is also known that the oxidized species 
dissociates to form a/x, a•/x•, b/y and c′/z• ions. However, it is not clear if c′ and  
z• ions also originate from dissociation of the CRS in EID of multiply charged 
species. Ion molecule reaction was used to investigate the origin of c′ and z• ions 
in EID spectra. 
It has been reported that z• ions produced in electron transfer dissociation 
react with molecular oxygen to form a z•+O2 adduct.
19 Baba has also reported on  
using molecular oxygen reactivity to distinguish between N and C terminal 
product ions formed in ECD.20 In this approach, known radical species e.g. z• 
react with O2 to form an adduct peak at m/z 32 Da higher but even electron c′ 
ions do not. Furthermore, it was shown, using the peptide neurotensin, that z• 
ions formed in HECD do not react with O2 while those formed in ECD did.
21 The 
observed differences were attributed to radical migration caused by the 
increased energy deposition from HECD. The hypothesis here is that z• ions in 
EID spectra should react with O2 if and only they form from the CRS.  
  The ECD spectrum of [VGVRVR+2H]2+ after O2 reaction in shown in 
Figure 4.21a. The observed z• ions are z3•, z4• and z5•. The z3•, z4• ions are O2 
reactive as expected. Surprisingly, it was found that the z5• did not react with 
molecular oxygen. This result is significant because it implies that two 
populations of z• ions exist in ECD. This is the first report of non reactive z• ions 
produced in ECD. The z5•
 ions formed in EID was also non reactive while the z3•,  
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Figure 4.21 MS/MS spectra of [VGVRVR+2H]2+ after molecular  oxygen reaction. 
a) Electron capture dissociation b) Electron ionization dissociation. Unreactive z5• 
ion is present in both spectra. 
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z4•, and z5
2+• ions reacted (Figure 4.21b). The z5
2+• ion is from dissociation of the 
oxidized species. It was expected that z• ions formed in EID would not react with 
O2 as in the case of z• ions formed in HECD, therefore, the observance of a 
reactive z• ion in EID is surprising.  The implication of this result is that O2 adduct 
formation alone is not sufficient to determine the z• ions formed from the CRS in 
EID.  
 An alternate approach is to measure the extent of O2 reactivity of z• ions 
from ECD and compare to that of EID. The hypothesis here is, if the radical site 
of z• ions produced in EID is the same as those produced in ECD then the O2 
reactivity should be the same. Molecular oxygen reactivity (R) is defined as the  
fraction of z• product ion population that reacts with O2 to form the O2 adduct. For 
simplicity the radical sign has been omitted. 
 =

 + 
 
Figure 4.22 is a plot of O2 reactivity of the z10
2+• ion produced from 
[substance P GKR+4H]4+ as a function of skimmer two repetition rate which is 
equivalent to the reaction time. As the reaction time increases the rate of adduct 
formation should also increase and this is the trend observed. It was found that 
the reactivity of z10
2+• ion produced from EID was the same as that of ECD. The 
same result was observed for z10
2+•, z11
2+• and z12
2+• ions of triply protonated 
neurotensin. These results suggest that the radical site of z• ions formed in EID is 
the same as that of ECD which further implies that c′ and z• ions in EID spectra 
can be formed via ECD mechanism i.e. dissociation of the CRS formed upon 
electron capture by the even electron parent ion. 
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Figure 4.22 Molecular oxygen reactivity of z10
2+• from [substance P GKR+4H]4+as 
a function of skimmer II repetition rate. The skimmer II repetition rate is 
essentially the reaction time. Error bars are standard deviation of triplicate 
measurements. 
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The O2 reactivity was studied for a variety of peptides and their z• ions for 
both ECD and EID (Table 4.5). In the table, z• ions formed in EID but absent in 
ECD spectra are denoted by N/A for not applicable. The non reactive z• ions are 
designated as no rxn (no reaction) in the table. The lack of O2 reactivity for some 
ions can be attributed to the radical site not being accessible to oxygen which 
would indicate a different structure from the reactive ions.  
4.3.9 Sources of Low Energy Electrons in EID Spectra 
The presence of abundant charge reduced species in EID spectrum of 
melittin implies that a significant population of low energy electron exists which is 
unexpected. One  source of low energy electron is due to secondary electrons 
formed upon ionization as shown in Equation 4.2.  Zubarev et. al. have reported 
that product ions observed in electron excitation dissociation of singly charged 
substance P were due to secondary electrons.5  In the electron energy 
dependence study of [FLEEV+H]+, the z4• ion of was observed at 10 eV. At this 
electron energy, ionization of the parent ion is possible. In the oxidation threshold 
experiments (Table 4.4) the measured threshold of oxidation for [substance 
P+H]+ was ~ 10 eV which confirms that ionization can occur at this electron 
energy.  Furthermore, formation of the z4• ion is necessarily due to reaction of the 
oxidized species as discussed earlier.  
To further confirm that low energy electrons originate from secondary 
electrons formed in the ionization process, the electron energy was varied and 
the appearance energy of the oxidized species and the CRS were monitored. 
The hypothesis here is: if low energy electrons originate from ionization then  
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Table 4.5 Molecular oxygen reactivity of protonated peptides 
Peptide z• Ion ECD 
Reactivity 
EID 
Reactivity 
[Angiotensin I+3H]3+ z5
1+ N/A 0.25 
 z5
2+ N/A 0.21 
 z6
1+ 0.18 0.17 
 z6
2+ N/A 0.19 
 z7
2+ 0.3 0.2 
 z8
2+ 0.13 0.15 
 z10
2+ 0.01 0.02 
 z10
3+ N/A 0.02 
[Bradykinin+2H]2+ z2
1+ N/A 0.2 
 z5
1+ 0.2 0.13 
 z6
1+ 0.12 0.16 
 z9
1+ 0.14 0.18 
 z9
3+ N/A 0.06 
[Angiotensin II+2H]2+ z3
1+ N/A 0.12 
 z7
1+ 0.25 0.31 
 z7
2+ N/A 0.2 
 z8
1+ 0.04 0.05 
[FLLVPLG+H]+ z4
1+ N/A No Rxn 
 z5
1+ N/A No Rxn 
[LFTGHPEpSLER +H]+ z2
1+ N/A No Rxn 
[ALILTLVS+H]+ z4
1+ N/A 0.4 
 z5
1+ N/A 0.45 
[VGVRVR+2H]2+ z4
1+ 0.47 0.57 
 z5
1+ No Rxn No Rxn 
[VGVRVR+3H]3+ z5
2+ No Rxn No Rxn 
[pELYENKPRRPYIL+3H]3+ z10
2+ 0.26 0.29 
 z11
2+ 0.16 0.14 
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oxidized species and the CRS should appear at approximately the same electron 
energy. Figure 4.23 is a plot of abundance vs. electron energy. The abundance 
of the parent ion, [M+3H]3+, the oxidized species [M+3H]4+•, and the CRS 
[M+3H]2+• are shown. Note that maximum dissociation is at ~ 30 eV and 
ionization, as indicated by the abundance of the oxidized species, is maximum at 
~ 20 eV. This is in agreement with the report that quantum yield of ionization is 
highest at ~20 eV.22 In the figure, the charge reduced species is not present in 
the low energy region because no fragmentation was observed for the same 
reason as that given for the efficiency plot. As shown in the plot, the CRS forms 
after the oxidized species which implies that there is no correlation between 
ionization and production of low energy electrons.  
Another possible source of low energy electrons is due to ionization of the 
helium buffer gas. The first ionization potential of helium gas is 24.586 eV23 
therefore ionization by the 30 eV electrons used in EID is possible. It is 
hypothesized that, if ionization of helium indeed occurs then the abundance of 
the CRS should increase at ~ 25 eV, the ionization potential of helium. To test 
this hypothesis, the electron energy was varied and the abundance of the CRS of 
[melittin+3H]3+ was monitored as before. Figure 4.23b is a plot of the CRS 
[M+3H]2+•abundance vs. electron energy. The region of linear increase was 
determined to be 23 ± 0.13 eV which is close to the ionization potential of helium. 
The discrepancy with the theoretical ionization energy of helium could be due to 
the few data points in the linear region. The experiment was repeated using 
methane as the buffer gas instead of helium. The plot of the CRS abundance as  
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a) Plot of abundance vs. electron energy showing [melittin+3H]3+ , 
[melittin+3H]4+•, and [melittin+3H]5+. Helium was used as the bath gas b) plot of 
the charge reduced species shown in a). Error bars are standard deviation of 
triplicate measurements  
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a function of electron energy is shown in Figure 4.24. The y-intercept was found 
to be 12.11 ± 0.83 eV which is, approximately, the literature value of methane 
ionization potential (12.51 eV).23 
The high helium pressure present in the cell may also contribute to the low 
energy electrons. To test this hypothesis, the abundance of the charge reduced 
species of [Melittin+4H]3+•, formed from [Melittin+4H]4+ was monitored as a 
function of the helium gas pressure. It was observed that the charge reduced 
species abundance increased as a function of pressure (Figure 4.25). The result 
can be interpreted as increased ionization of the bath gas due to the greater 
number density of helium at increased pressure. 
4.3.10 N/C Terminal Differentiation in de novo Sequencing 
Tandem mass spectrometry data is generally searched against a genomic 
or protein database search for protein identification. In the case of an organism 
whose genome has not been sequenced and therefore not known, de novo 
sequencing is required. Another motivation for de novo sequencing is the 
possibility of errors either with the database or a result of modification in the 
protein synthesis pathway. Protein synthesis proceeds according to the central 
dogma i,e DNA (deoxyribonucleic acid) replication, DNA transcription to RNA 
(ribonucleic acid), and RNA translation into protein.24  Alternative splicing after 
transcription and chemical modifications after translation can occur.  
 A major part of de novo sequencing pertains to distinguishing the N- and 
C terminal ends of a peptide. Baba reported on the use of molecular oxygen 
reactivity to distinguish the terminal product ions formed in ECD.20 Radical z ions  
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Figure 4.24 Plot of the charge reduced species, [melittin+4H]3+•, abundance vs. 
electron energy using methane as the bath. The y-intercept of the linear region 
corresponds to the first ionization potential of methane. 
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Figure 4.25 Abundance of the charge reduced species, [melittin+4H]3+•, as a 
function of helium gas pressure 
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react with O2 but even electron c′ ions do not. Horn et. al. proposed a method in 
which mass difference between product ions due to backbone cleavages are 
used to distinguish between the N/C terminals.25  In their method data from ECD 
and CID are combined.  A mass difference of -17.03 Da (i.e. b – c′) corresponds 
to N-terminal product ions and +16.02 Da i.e. y - z• is indicative of the C-terminal 
product ions.  
The approach detailed here is similar to the one above but because EID 
gives all product ion types, a separate CID experiment is not necessary. As 
shown in Figure 4.26, the difference in mass between a and b ions is 28 Da, and 
the difference in mass between c′ and b ions is 17 Da. Starting at a given peak a 
28 Da mass difference followed by a 17 Da mass difference corresponds to the 
N-terminus and a 26 Da then 16 Da mass difference is indicative of C-terminal 
fragment.  This method does not require two separate MS/MS experiments. 
4.3.11 Analysis of Phosphorylated Peptides 
Protein phosphorylation is one of the most common post translational 
modifications (PTMs) in eukaryotes and plays a significant role in cell signaling.26 
It consists of the addition of phosphate group to a protein. O-phosphorylation 
targets serine, threonine and tyrosine amino acids. It is reported that 16 % of 
amino acids in the NCBI protein database are serine, threonine or tyrosine which 
makes the chances of a peptide containing more than one of these residues 
high.26 In order to determine the modified residue(s) the modification must be 
retained upon dissociation and the sequence coverage should be high. The 
commonly used methods are ECD and CID. ECD is known to preserve PTMs  
  
 
 
 
 
 
 
 
Figure 4.26 Approach to distinguish N/C terminus of product ions 
difference between product ions 
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and noncovalent interactions upon backbone cleavage but the intact interactions 
can prevent observance of sequence ions which are necessary to locate the 
modification site. In CID, the PTMs are often lost which hinders localization of the 
modified site. It is hypothesized that EID will be better suited for the analysis of 
phosphopeptides because high sequence coverage is often obtained and the 
phosphorylation should be retained to a greater extent than in CID. 
The applicability of EID for the localization of phosphorylated amino acid 
residues was studied and compared to CID and ECD. The CID spectrum of 
phosphorylated peptide [LFTGHPEpSLER+H]+ is shown in Figure 4.27a. O-
phosphorylation targets serine, threonine and tyrosine amino acids as mentioned 
therefore either the threonine or the serine residues could contain the 
modification. In the spectrum, the most abundant peak corresponds to the loss of 
phosphoric acid. While the peak confirms that the peptide is indeed 
phosphorylated, it also means that the modification may have been lost. The 
observed sequence ions are: b7, b10+80, y3, y4+80, y6+80, y8+80, and y9+80. An 
80 Da mass shift is due to the dehydration reaction that occurs upon 
phosphorylation and therefore indicates modified residues. Loss of 98 Da from 
the sequence ions are not included in the list because they often correspond to 
water loss from unmodified residues and therefore cannot be used for direct 
validation of the modified residue(s). As mentioned, there are two possible 
modification sites in the peptide, threonine or serine. The b10+80 ion indicates 
that either the serine or threonine have been modified which is not informative.  
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Figure 4.27 MS/MS spectra of [LFTGHPEpSLER+H]+ a) collision induced 
dissociation b) electron ionization dissociation 
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The y3 ion is also not informative because the modified residues are not 
contained in the ion. From the ions: y4+80, y6+80, y8+80, y9+80 ions the modified  
residue can be assigned as serine. The b7 ion further verifies that the 
modification is not on threonine. The EID spectrum of the peptide is shown in 
Figure 4.27b. 98 Da loss from the parent is virtually absent. Additionally, no 98 
Da loss from the oxidized species was observed but losses of carbon dioxide and 
91Da due to phenylalanine side chain were present. The backbone cleavage 
ions include: a2, a3, a6, a7, b2, b5, x5+80, x6•+80, z2, z3, and z4+80. From these 
ions the modification site can be assigned to the serine residue. 
The doubly phosphorylated peptide, [HEVSASpTQpSTPASSR+2H]2+,was 
also studied.  Figure 4.28a is the ECD spectrum of the peptide. Only the z10•+80 
backbone cleavage ion is observed. However abundant charge reduced peak is 
present which is indicative of non dissociative electron capture. The non 
dissociative electron capture can be attributed to intact noncovalent interactions 
therefore, activated ion ECD is required to break the intramolecular interactions 
for sequence ions to be observed. From this spectrum, the modified residue 
cannot be determined.  
The EID spectrum of the peptide is shown in Figure 4.28b. The CRS is 
also observed but to a lesser extent. However, product ions from backbone 
cleavage are readily observed without the need for supplemental activation. Also, 
no phosphoric acid loss from the parent ion or from the oxidized species was 
observed. Observed a4, a5, b4, b5, b6, c4′ ions imply that the serine residues at  
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Figure 4.28 MS/MS spectra of [HEVSASpTQpSTPASSR+2H]2+, a) electron 
capture dissociation b) electron ionization dissociation 
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position 4 and 6 (S4 and S6) are not modified. The x2, x3, y2, y3, y4, y5, y5
2+, y6, 
z2•, z3•, z4• ions imply that T10, S13 and S14 are not modified. Therefore the  
phosphorylated residues must be T7 and S9. An a12
2++80 ion further confirms the 
assignment.   
The CID spectrum is shown in Figure 4.29. As before, the most abundant 
ions are due to loss of the phosphoric acid moiety. The backbone cleavage ions 
observed are: b2 – b6, b8+80, b10+80, y2, y5, y6, y8+80, y10+80, y11+80, y12+80 and 
y13+80. From the C-terminal ions, the modified residue cannot be S13, S14 or 
T10 (i.e. serine residues at position 13, 14 or threonine residue at position 10). 
From the b2 – b6 N-terminal ion series, the modified residues are not S4 or S6 
which leaves T7 and S9 as the modified amino acid residues.  
Table 4.6 gives a summary of the results from all phosphopeptides 
studied. Localization of the modified residue (s) was possible for all the peptides 
studied using CID. However, the abundance of the sequence ions was relatively 
low which decreases the confidence of the assigned modification site. The 
modification site in two of the peptides could not be determined using ECD 
because of insufficient backbone cleavage ions.  Only in one case, 
[LNQSpSPDNVTDTK+2H]2+ was the modified residue unable to be identified 
using EID. The observed ions were a3, a6+80, a9
2++80, b2, b3, b5+80, b9
2++80, 
c12′+80, x2, x3, x5, x7, x10
2++80, y2, y3, y4, y6, y8 and z2• –z7•. From the z2• –z7• ion 
series alone, it could be determined that the threonine residues were not 
modified. However, the modified serine residue could not be assigned because  
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Figure 4.29 Collision induced dissociation of [HEVSASpTQpSTPASSR+2H]2+ 
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Table 4.6 Sequence coverage of phosphorylated peptides using electron capture 
dissociation, electron ionization dissociation and collision induced dissociation. 
Bolded font indicates the method which gave the highest sequence coverage. 
Asterisk indicates that the phosphorylation site could not be located. 
     
 
Peptide 
 
Charge 
State 
 
ECD 
(%) 
 
EID (%) 
 
CID (%) 
LFTGHPEpSLER 1 - 60 60 
 2 80 100 90 
 3 100 90 80 
LFpTGHPESLER 1 - 90 60 
 2 50 100 80 
 3 100 100 80 
ALSGRApSPVPAPSSGLHAAVR 3 70 80 85 
 4 85 70 65 
HEVSASpTQpSTPASSR 2 7* 71 71 
LNQSpSPDNVTDTK 2 50* 83* 75 
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no backbone cleavage between S4 and S5 was observed. EID gave the highest 
sequence coverage for more peptides than ECD and CID. Although, a high  
sequence coverage does not necessarily result in a positive assignment, as in 
the case of [LNQSpSPDNVTDTK+2H]2+, in general, the greater the number of 
backbone cleavage ions the better the chances of locating the modified 
residue(s).  Also, loss of the phosphoric acid group was minimal or absent in 
most spectra. These results show that extensive backbone cleavage as well as 
retention of the PTM is important for site localization of modified peptides.  
Because EID does both, it is a viable alternative to both CID and ECD for 
localization of phosphorylation sites. Also, EID is complementary to ECD 
because singly charged analytes can be studied. 
4.3.12 Analysis of Sodiated Molecules 
4.3.12.1 Peptides 
Collision induced dissociation of protonated peptides typically results in 
product ion formation from both the N and C terminus which can complicate 
spectral interpretation. Conversely, sodium cationized peptides fragment by loss 
of the C-terminal residue to form product ion that is an amino acid shorter than 
the original peptide.27 The approach has been used for C-terminal peptide 
sequencing.28 The dissociation pattern of sodiated peptides using electron 
ionization dissociation was studied and compared to that of CID. The CID 
spectrum of sodiated YGAFL is shown in Figure 4.30a. Dissociation mainly 
resulted in loss of leucine residue although minor products from backbone  
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Figure 4.30 MS/MS spectra of [YGAFL+Na]+, a) collision induced dissociation b) 
electron ionization dissociation 
 
 
 
200 300 400 500 600
0
2000
4000
6000
8000
10000
12000
14000
[a
4
+Na-H]
+
[b
4
+Na-H]
+
[M+Na]
+
-L
[M+Na]
+
A
b
u
n
d
a
n
c
e
m/z
200 300 400 500 600
0
10000
20000
30000
40000
50000
60000
70000
80000
90000
100000
x
4
/[a
4
+Na-H]
+
[M+Na]
2+•
-NH
3
[M+Na]
2+•
b
3
[y
3
+Na-H]
+
[c
3
'+Na-H]
+
[M+Na]
+
-107 Da
[M+Na]
+
-H
2
O
[M+Na]
+
-L
[M+Na]
+
x5
A
b
u
n
d
a
n
c
e
m/z
b) 
a) 
135 
 
cleavage between phenylalanine and leucine were also observed. The EID 
spectrum was very different in that the base peak was that of tyrosine side chain  
loss plus H•, -107 Da (Figure 4.30b). A peak corresponding to C-terminal loss of 
leucine residue was present as in the case of CID. Additionally, water loss from 
the parent ion along with N and C terminal product ions due to backbone 
cleavage were evident in the spectrum.  
It was observed that phosphorylated peptides dissolved in H2O readily 
form sodium adducts. Multiple sodium adducts were observed at higher 
abundance than the protonated form. To explore the utility of EID for analysis of 
the sodiated ions, singly and doubly sodiated ions were selected for MS/MS.  
CID of the phosphorylated peptide, [LFTGHPEpSLER+H+Na]2+, resulted 
exclusively in  the  loss of the phosphoric acid moiety hence no sequence 
information was obtained (Figure 4.31). Conversely, 90 % sequence coverage  
was achieved using EID although some phosphoric acid loss from the parent ion 
was observed (Figure 4.32). The abundant 86 Da loss from the parent 
corresponds to C3N3H8 from arginine. Although a high sequence coverage was 
obtained, spectral interpretation was complicated by N and C terminal product 
ions, some protonated and others sodiated which made localization of the 
phosphorylated residue tedious.  Similar results were obtained for doubly 
sodiated peptides. 
4.3.12.2 Oligosaccharides 
Glycosylation, the attachment of oligosaccharides, is the most common 
post translational modification in eukaryotic proteins.29 Oligosaccharides consist  
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Figure 4.31 Collision induced dissociation of [LFTGHPEPpSLER+H+Na]2+. No 
backbone cleavage product ions are observed. 
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Figure 4.32 Electron ionization dissociation spectrum of 
[LFTGHPEpSLER+H+Na]2+. The sodium adduct cannot be located a priori which 
complicates spectral interpretation. 
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of short chains of simple sugars joined by a glycosidic bond. There are at least 
eight common sugar mononers and multiple linkage types which makes analysis 
of glycosylated proteins challenging. Tandem mass spectrometry has been 
successfully used to elucidate carbohydrate structure.27 The nomenclature for 
dissociation of oligosaccharides as described by Domon-Costello30 is shown in 
Figure 4.33. If the glycosidic bond is cleaved and the charge is retained on the 
carbohydrate portion then Ai, Bi and Ci product ions are formed. The number of 
glycosidic bond cleaved starting from the non reducing end is designated by i. 
Conversely, if the charge is retained on the reducing end, then, Xj, Yj, and Zj, ions 
are formed, where j represents the number of glycosidic bond starting from the 
reducing end. Cleavage of the carbon-carbon bond of the sugar ring, termed 
cross ring cleavage, is also possible. Product ions are named Ai and Xj as in the 
glycosidic bond cleavage nomenclature but superscripts are added to identify the 
C-C bond that is cleaved. 
The CID spectrum of maltotetraose, a tetrasacharide with four glucose 
monomers in a [glucosyl(α1→4)glucose] linkage, is shown in Figure 4.34a.  The 
spectrum is dominated by to glycosidic bond cleavage ions. The glycosidic bond 
cleavage ions indicate the number of monomer units but no information about the 
glycan structure.  In much lower abundances are three 0,2Xj and 
2,4Xj cross ring 
cleavage ions and one 2,4Ai type ion. The EID spectrum (Figure 4.34b), however, 
contains a variety of abundant cross ring cleavage product ions. In addition to the 
0,2Xj, 
2,4Xj, 
2,4Ai ions observed in CID, 
1,5Xj, and 
3,5Ai are present which are 
essential for determining monomer to monomer linkage type.  
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Figure 4.33a) Domon-Costello carbohydrate fragmentation nomenclature b) 
numbering of the cross ring cleavage28    
a) 
b) 
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Figure 4.34 MS/MS of sodiated maltatetraose a) electron ionization dissociation 
b) collision induced dissociation. Loss of104 is due to a loss of C4H8O3 as a 
result of a 2,5 cross ring cleavage. 
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4.4 Conclusions 
In EID, dissociation is possible from multiple species, the parent ion, the 
singly and doubly oxidized species, and the charge reduced species. Therefore, 
EID gives many product ions which generally result in higher sequence coverage 
as compared to CID and ECD. The hydrogen deficient oxidized species formed 
in EID fragments differently from the hydrogen abundant species formed in ECD. 
This is one reason that activation of the oxidized species does not lead to a 
significant increase in product ion abundance and sequence coverage as is often 
observed in activation of the charge reduced species. Also, even electron ions, 
like the dissociating species in CID, fragment differently from odd electron 
species.  
Radical z ions formed in EID react with molecular oxygen to the same 
extent as those formed in ECD which suggests that the charge reduced species 
observed in EID spectra can dissociate to forms c′ and z• ions. However, O2 
reactive z5
2+• ion observed in EID spectrum of [VGVRVR+2H]2+ suggests that 
parent ion internal energy  may not be important for O2 reactivity. 
EID is useful for the analysis of phosphorylated peptides (both singly and 
multiply charged) because the modification is largely conserved upon 
dissociation and extensive backbone cleavage is often achieved. For small (5 
residues) sodiated peptides EID can be more informative than CID because side 
chain losses are observed in addition to loss of the C-terminal amino acid 
residue. EID of sodiated oligosacharides results in abundant cross ring cleavage 
ions which are imperative for structural characterization of sugar monomers. 
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Chapter 5
Identification and Characterization of Class I MHC Presented 
Peptides on Leukemia  
5.1 Introduction and Background 
The purpose of this work is to identify class I major histocompatibilty 
complex (MHC) presented peptides on leukemia cells for use as anti-cancer 
immune targets. The immune system1, 2 is the body’s defense against pathogens 
and is therefore, vital for survival. The mechanism of protection against infections 
can be divided into two categories: innate immunity and adaptive immunity. 
Innate immunity is the first line of defense against invading organisms and 
constitutes defense mechanisms that are present even before infection and 
ready to be mobilized upon infection. Adaptive immunity is able to respond to 
specific molecular factors (antigens), and the response can adapt to become 
more specific and potent.  Additionally, adaptive immunity does develop memory 
so that re-exposure to the same pathogen leads to a more rapid immune 
response.  Innate immunity does not have a memory component and pathogen 
recognition is mediated by identification of generic molecular motifs not specific 
antigens. Adaptive immunity can be humoral or cell-mediated. Cellular immunity 
is mediated by lymphocytes (T, B and natural killer cells) and is important in the 
control of intracellular pathogens such as viruses.  Additionally cellular immunity 
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is important in the control of some cancers particularly hematologic malignancies, 
melanoma, and renal cell carcinoma 
The major histocompatibility molecules are essential to adaptive immunity. 
MHC molecules are proteins expressed on the cell surface whose function is to 
display peptide fragments of proteins for recognition by T lymphocytes. MHC 
molecules are sub divided into three classes: class I, II and III. However, only 
class I and class II MHC can present antigens. Class I MHCs are expressed on 
the surface of all nucleated cells and consists of two non-covalently linked 
polypeptide chains, heavy or α chain (44 kDa) and β2-microglobulin (β2m) of 12 
kDa.  The polymorphic α chain, is encoded by MHC genes and is subdivided into 
three domains: α1, α2 and α3. The α3 domain interacts with T lymphocytes while 
α1 and α2 form a groove where peptides of 8-10 amino acid residues bind. β2m 
is non polymorphic and is not encoded within the MHC gene.  
In the MHC class I presentation pathway, proteins in the cytocol are 
ubiquitinated and then degraded by the proteasome to form peptides.3, 4 The 
transporter for antigen processing (TAP) then translocates peptides into the 
endoplasmic reticulum (ER). In the ER the MHC class I molecules are loaded 
with peptides. The peptide-MHC-β2m complex is finally transported to the cell 
surface, where the peptide is displayed for recognition by CD8+ T cell, the MHC I 
restricted cytotoxic T lymphocyte. The human MHC class I molecules are called 
HLA (human leukocyte antigen) A, B, and C. HLA alleles are highly polymorphic 
and polygenic and are grouped based on similar peptide binding specificities 
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termed supertype.5, 6 In this work peptides presented by the HLA-A*0201 MHC 
supertype are identified for use as anti-cancer immune targets.   
5.2 Materials and Method 
5.2.1 Tissue Culture 
Mouse hybridoma line HB-82 (source of the anti-HLA-A*0201 antibody 
BB7.2), U937 leukemia cell lines stably transfected with either wild-type or a 
mutated form of HLA-A0201 were grown under sterile conditions at 37 °C with 
5% CO2 in a medium consisting of RPMI 1640 supplemented with heat 
inactivated 10 % (56 °C for 30 minutes) fetal bovine serum (FBS), 1 % penicillin 
streptomycin, and 1 % L-glutamine.  The complete medium was filtered using a 
0.22 µm polyether sulfone (PES) membrane and stored at -4 °C.  
5.2.2 Antibody Isolation 
Mouse hybridoma line HB-82 was grown to yield 3 x 1012 cells and the 3L 
of resulting supernatant the contained the secreted BB7.2 IgG2b antibody were 
collected.  The 3 L supernatant was concentrated to 150 ml using Centricon 
Plus-70 centrifugal filter device with 100 kDa molar mass cut-off. The concentrate 
was then affinity purified. A 5 ml GE Healthcare HiTrap™ rProtein A FF column 
packed with recombinant protein A sepharose was used for antibody purification. 
Affinity purification was performed using AKTAprime fast protein liquid 
chromatography (FPLC) instrument by Amersham Pharmacia Biotech AB 2000. 
A 20 mM Tris-HCl, pH 8, equilibration buffer i.e buffer A and a 0.2 M sodium 
acetate buffer, buffer B, pH 3.25 was used. After equilibration with buffer A the 
150 mL of concentrated supernatant were loaded onto the protein A column.  
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Protein A has a very high affinity for the Fc portion of antibodies so the BB7.2 
was retained while the other proteins in the supernatant were passed through the 
column.  BB7.2 was eluted from the protein A column by changing the running 
buffer to the low pH, high salt buffer B. 50 ml of BB7.2 IgG2b was collected and 
further concentrated to 10 ml. Concentration of the antibody was determined to 
be 6.2 mg/ml using the Bradford assay. 
5.2.3 Isolation of HLA-A*0201 Peptides 
Approximately, 6 x 109 cells were lysed in 20 mM Tris-HCl, pH 8, 150 mM 
NaCl, 1 % (m:v) 3- [(3-cholamidopropyl) dimethylammonio]-1-propane sulfonate  
(CHAPS), 1 mM (phenylmethylsulfonyl fluoride), 10 µg / mL pepstatin, 5 µg / mL 
aprotinin, and 10 µg / mL Leupeptin. The cell lysate was subjected to ultra 
centrifugation at a 100,000 g (40,000 rpm) using a Beckman L7 ultracentrifuge 
and a TY 70.1 TI rotor for 1 hour at 4 °C.  A. The supernatant was collected and 
affinity purified using a 1 mL GE Healthcare HiTrap™ rProtein A FF column 
modified with recombinant protein A sepharose. For affinity purification, 1mg /mL 
of purified BB7.2 antibody was first loaded onto the column.  The cell lysate was 
then applied to the column after equilibration. The Fab portion of BB7.2 
specifically binds HLA-A2 molecules.  During the washing step all unbound 
proteins were removed and the bound protein was eluted with 0.2 M aqueous 
acetic acid solution. Five 1 ml fractions were collected into silicon coated 
eppendorf vials and pooled together in a 10 mL eppendorf container. The 
concentration of acetic acid in the solution was adjusted to 10 % to separate the 
HLA molecule from β2-microglobulin (β2m) and the peptides. The solution was 
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filtered using a 3 kDa molecular weight cut-off (MWCO) membrane and the 
filtrate i.e. peptides were collected and stored at -80 °C. 
5.2.4 Western Blot 
Aliquots for the protein mixture from the whole cell lysate, non-bound 
fraction, column eluate, acid denatured eluate, 3 kDa filtrate, and 3 kDa 
retentatate were quantified for protein content using a Bradford assay, and 
equivalent amounts were run on a NuPAGE Novex Tris-Acetate minigel using 
Invitrogen XCell II™ Blot ModuleEI905.  The separated proteins were transferred 
to an Immobilon™ 0.45 µm polyvinylidene fluoride (PVDF) membrane by 
Millipore.  The membrane was cut at MW of 20 kDa.  The low MW membrane 
fragment was incubated with mouse anti-β2m IgG, and the high MW fragment 
was incubated with mouse anti-HLA-A2.  After washing both membranes were 
incubated with HRP-conjugated rabbit anti-mouse IgG.   
5.2.5 Liquid Chromatography / Mass Spectrometry 
A NanoFrontier Nano liquid chromatography / Linear ion trap time-of-flight 
mass spectrometer was used for online LC/MSMS experiments. A MonoCap 
monolithic trap column was used prior to the analytical column. Separation is 
achieved on a nano LC column (75 µm I.D. x 150 mm) packed with Vydac C18 (5 
µm particles) at a flow rate of 200 nL/min and a 60 minute gradient of 5 % to 70 
% solvent B.  Mobile phase A composed of 98 % H2O, 2 % acetonitrile and 0.1% 
formic acid. Mobile phase B consisted of 98 % acetonitrile, 2 % H2O and 0.1% 
formic acid. 1 µL of the purified peptide was injected and data dependent 
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acquisition mode was used. Collision induced dissociation (CID) was the MS/MS 
activation method employed. 
Offline fractionation was done with a Hitachi L-2000 HPLC system with UV 
detection at 214 nm wavelength.  A C12, Jupiter Proteo, 4 µm, 90 Å, 150 x 2 mm 
reversed phase column by Phenomenex was the analytical column used.  The 
same solvent system used for the online experiment was used.1 mL fractions 
were collected for 40 minutes.  Each of forty fractions was subjected to online 
LC-MS/MS as described earlier. 
5.2.6 Database Search 
MS/MS ion search was performed using Mascot, no enzyme, search. The 
comprehensive, non identical protein database (NCBInr) was used to perform the 
search.  0.2 Da peptide and MS/MS tolerance was used.  Peptide tolerance 
refers to the error window on experimental peptide mass value and MS/MS 
tolerance refers to the error window on experimental CID product ion mass 
values. No fixed or variable modifications or missed cleavages were selected. De 
novo sequencing was performed using in-house programs written in LabVIEW 
(National Instrument). 
5.2.7 Peptide Characterization Methods 
The immune epitope database (IEDB) epitope prediction and analysis tool 
was used to predict MHC I binding of Mascot derived sequences: 
http://tools.immuneepitope.org/analyze/html/mhc_binding.html. The basic local 
alignment search tool (BLAST) was used to determine the source protein of 
identified peptides: http://blast.ncbi.nlm.nih.gov/Blast.cgi.  The gene portal system 
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(BioGPS) was used to determine tissue expression: http://biogps.gnf.org, and the 
ensembl database, http://uswest.ensembl.org/index.html was used to determine 
possible allelic variation in the peptides. 
5.3 Results and Discussion 
5.3.1 Peptide Identification 
HLA-A*0201 transfected, U937 leukemia cell line cells were cultured, lysed and 
cleared using ultra centrifugation. Figure 5.1 is a western blot documenting the 
purification procedure. Because of the complexity of the sample HLA molecules 
are not expected to be present at a high concentration after ultra centrifugation 
as shown in Lane A.  After affinity purification of the cleared cell lysate, the HLA-
A*0201- β2m-peptide complexes are isolated as evident in Lane B. The antibody 
light and heavy chains are also observed. Acid denaturation breaks the complex 
into individual entities i.e. the HLA molecule, β2m and peptides. The low molar 
mass (~1 kDa) peptides are then isolated via a 3 kDa MWCO filter. HLA-A*0201, 
β2m and antibody chains which are too large to pass through the filter are absent 
(Lane D). The filtrate contains the HLA presented peptides which are too small to 
be detected on the gel.  
 Affinity purified HLA-A*0201 peptides were separated using reversed 
phase liquid chromatography. The total ion chromatogram is shown in Figure 5.2. 
The most abundant ion elutes at 26.27 minutes and corresponds to a singly 
charged peptide at m/z 918.5. The second most abundant ion is a singly charged 
ion at m/z 615.5. This ion is too small to be an HLA-A*0201 presented peptide 
and is likely a contaminant or fragment from HLA molecule, antibody or β2m due  
  
 
 
 
 
 
 
 
 
 
Figure 5.1 Western blot of purified leukemia lysate. Protein extracts from cleared 
cell lysate (A), affinity column eluate (B),
(D), 3 kDa retentate (E) are shown. The western blot membrane was cut at ~ 20 
kDa before primary antibody was added. The high Mr membrane was incubated 
with mouse anti-HLA-A2 and the low Mr membrane was incubated 
anti-β2 microglobulin (β2m) IgG, which associates with native HLA
antibody was HRP-conjugated goat
antibody, bb7.2 (bands IgG HC and IgG LC), HLA
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Figure 5.2 Mass spectrometry total ion chromatogram (TIC) of HLA-A*0201  
3 kDa filtrate. 
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to acid denaturation step. Other such peaks are present in the chromatogram. 
The remaining peaks correspond to HLA peptides. The extracted ion 
chromatograms of select peptides are given in Figure 5.3 a-c.  
From the LC-MS/MS data a Mascot generic file which consists of the 
parent ion mass-to-charge value and the CID data is created. The data are 
subjected to a Mascot MS/MS ion search using the parameters in Figure 5.4. 
Two peptides returned a unique match. One matched to neutrophil elastase 
(ELANE) and the other to capthesin G (CTSG). The CID spectra used to make 
the identification are shown in Figure 5.5. Sequence coverage of 89 % was 
obtained for the peptides, LLLGGTALA and FLLPTGAEA.  All other peptide ions 
gave no significant matches (Mascot score < 60) and were therefore subjected to 
manual analysis. Mascot provides a list of all possible sequences matching the 
parent ion molar mass and the CID fragmentation pattern. These sequences 
were checked using in-house software written in Labview. The program predicts 
backbone cleavage product ions based on the Mascot derived sequences. The 
experimental data is then compared to the predicted values and product ion 
assignment is made based on mass accuracy and the isotope distribution. From 
this information the correct sequence from the Mascot list is determined. One 
peptide identified using this approach is ALTPVVVTL and its mass spectrum is 
shown in Figure 5.5c. Sequence coverage of 75 % was obtained for the peptide 
from b and y backbone cleavage ions. 
Additionally, all sequences were further verified using the Immune Epitope 
Database (IEDB) resource’s artificial neural network (ANN) algorithm. The IEDB  
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Figure 5.3 Extracted ion chromatogram select HLA-A*0201 presented peptides 
a) LLLGGTALA b) ALTPVVVTL c) FLLPTGAEA   
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Figure 5.4 Screen shot of Mascot search parameters used to identify HLA- 
A*0201 presented peptides. 
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Figure 5.5 Collision induced dissociation spectra used to identify HLA-A*201 
peptides a) [LLLGGTALA+2H]2+ b) [FLLPTGAEA+2H]2+ c) [ALTPVVVTL+H]+ 
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predicts MHC I binding using the half maximal inhibitory concentration IC50 
values. Peptides with IC50 < 50 nM are predicted to tightly bind to HLA 
molecules. Table 5.1 is the list of HLA A*0201 identified peptides including the 
retention time and IC50 values. Some of the peptides are isobaric and elute at the 
same retention times. Examples are: ILLAAVPTA, LLIPGLATA and LLIENVASL, 
LLIERGASL. The CID spectrum is therefore a convolution of the two fragmenting 
species and would be impossible to sequence de novo. However, because 
Mascot gives all possible sequences that match the MS and MS/MS data the 
isobaric peptides could be identified. 
It theory, thousands of peptides are processes and presented by HLA 
molecules, although the dynamic (> 10,000 species in a range of 1 – 10,000 
copies)7 posses a significant analytical challenge. In an attempt to increase the 
number of peptides identified offline fractionation was performed.  Over an order 
of magnitude increase in peptide ion abundance was observed for the peptide.  
Table 5.1 Identified HLA-A*0201 peptides, retention time, IC50 and mass. 
Highlighted peptides are isobars i.e. same mass-to-charge values. Peptides with 
no indicated retention time were identified in a different experiment. 
FLLPTGAEA. However, no new peptides were identified. As a consequence of 
the increased peptide abundance, Mascot scores and expect values were greatly 
improved. An example is shown for FLLPTGAEA (Figure 5.6). In the case of 
online analysis alone the score and expect value were 63 and 0.022 respectively.  
Offline fractionation prior to online LC-MS gave a score of 71 and an expect 
value of 0.0017. 
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Table 5.1 Identified HLA-A*0201 peptides, retention time, IC50 and mass. 
Highlighted peptides are isobars i.e. same mass-to-charge values. Peptides with 
no indicated retention time were identified in a different experiment. 
  
Peptide tr (min) IC50 [M+H]
+ 
FLLPTGAEA 26.27 20.1 918.5 
LLLGGTALA 27.65 29.1 828.5 
LLDVPTAAV 26.1 43.8 898.5 
SLAGGIIGV 27.41 9.4 786.5 
ALTPVVVTL 29.89 46.9 912.6 
ILLAAVPTA  30.37 19.7 868.6 
LLIPGLATA 30.37 29.2 868.6 
LLIENVASL 30.44 13.5 971.6 
LLIERGASL 30.44 29.2 971.6 
ALPEIFTEL 35.26 18.1 1032.6 
SLQEEHVAV 30.23 31.7 1011.5 
ALSEKIVSV 28.06 10.2 945.6 
FLISLVFLL 34.09 6.7 1064.7 
ALFPGVALL 26.03 12.5 900.6 
SLLPAIVEL 35.81 10.3 954.6 
KLLVTVTAV - 15.1 944.6 
LLIAVNSPV - 10.7 925.6 
ALTGWLPEV - 7.8 985.5 
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Figure 5.6 Mascot search result a) online LC MS/MS using a C18 reverse phase 
column b) offline fractionation using C12 column with UV detection followed by 
online LC MS/MS using a C18 reverse phase column 
 
  
b) 
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Table 5.2 Identified HLA-A*0201 presented peptides and their gene family. 
Peptides in bold are from proteins detected only on the mRNA levels. 
   
Peptide Gene 
FLLPTGAEA Cathepsin G  
LLLGGTALA Neutrophil elastase  
LLDVPTAAV Interferon gamma inducible protein 30 
SLAGGIIGV Heterogeneous nuclear ribonucleoprotein K 
ALTPVVVTL Cyclin dependent kinase 4 
ILLAAVPTA  Major facilitator superfamily domain containing 2B 
LLIPGLATA NADH dehydrogenase 1 alpha subcomplex subunit 1 
LLIENVASL Glutathione peroxidase 1 
LLIERGASL NY-BR-16  
ALPEIFTEL Eukaryotic translation initiation factor 2, subunit 3 
SLQEEHVAV Plectin-1 
ALSEKIVSV Coiled-coil domain containing protein 93 
FLISLVFLL T-cell differentiation protein-like 
ALFPGVALL Protein disulfide isomerase family A, member 3 
SLLPAIVEL Protein phosphatase 2, regulatory subunit A, alpha and B, 
beta 
KLLVTVTAV Synaptotagmin-14  
LLIAVNSPV Schlafen family member 14 
ALTGWLPEV Calpain-7-like protein 
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5.3.2 Peptide Characterization 
Examination of the identified peptides reveals certain structural motifs. All 
peptides contain nine amino acid residues and display a conserved leucine 
residue at position 2 and limited (alanine, leucine, valine) variability in position 9. 
It is known that the peptide binding site of the MHC class one molecule contains 
six pockets (A-F). Of the six pockets, two are directly involved in peptide binding: 
the B and F pockets. The peptide’s N-terminal end is anchored in position 2, the 
B pocket, and the C-terminus is contained in position 9, the F pocket. The 
findings here support the prior observations that the B pocket anchor for the 
HLA-A*0201 are small aliphatic residues while the F pocket anchor are small, 
aliphatic hydrophobic residues.6 
Although the genes from which the peptides are derived are known (Table 
5.2) 33 % of the peptides are from proteins that have only been detected on the 
mRNA level therefore the protein function in the cell is unclear. These peptides 
are in bold and are LLIPGLATA, ALSEKIVSV, FLISLVFLL, KLLVTVTAV, 
LLIAVNSPV, and ALTGWLPEV.  Several other peptides could be good targets 
for therapeutic applications based upon such issues as their tissue distribution  
and immunogenicity.  Immunotherapy trials directed at cancer associated 
antigens have already been performed, and several of the peptides discovered in 
this study have a narrow tissue distribution for hematopoietic tissue, which could 
make them good targets for myeloid leukemia directed therapy.   
Several peptides that were identified have interesting properties that may 
make them candidate anti-cancer immune targets.  Ankyrin repeat domain 17 
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(ANKRD17), the protein from which LLIERGASL is derived, is the source protein 
from which the breast cancer antigen NY-BR-167 is found suggesting that this 
protein is expressed in multiple cancer types and may be a good source of 
antigens for various HLA supertype. ALTPVVTL is from the cyclin dependent 
kinase 4 protein (CDK4), a member of the protein kinase superfamily.  CDK4 is 
implicated in integrating oncogenic signaling and inactivation of the tumor 
suppressor Rb.8 CDK4 small molecule inhibitors have been developed as 
potential cancer therapeutics, and an immune therapy aimed at this regulatory 
protein could be developed.9 Finally, LLLGGTALA is derived from the protein 
neutrophil elastase (ELANE) which is the source protein of the leukemia 
associated antigen PR1.10, 11 
In addition, a deletion polymorphism has been reported for the 
ALFPGVALL peptide, which would cause a frame shift mutation starting from the 
F pocket.  If this polymorphism leads to a peptide that is unable to bind HLA-
A*0201, the ALFPGVALL peptide could be a leukemia associated, minor 
histocompatibility antigen. Minor histocompatibility antigens12 are important in 
effecting cures for leukemia patients who undergo allogeneic stem cell 
transplantation because the donor’s T lymphocytes have never been tolerized to 
the allelic form of the peptide produced by the recipient/patient.13  In the case of 
ALFPGVALL, if the donor is homozygous for the allele that yield the frame-shift 
mutation, the donor’s T lymphocytes which are transferred into the patient during 
the transplant procedure will have never “seen” the ALFPGVALL peptide and will 
regard it as foreign leading to immune-mediated attack of the cell presenting 
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ALFPGVALL.  Another peptide, FLLPTGAEA, is derived from cathepsin G and 
contains an A/G polymorphism in position 6, which could also make it a minor 
histocompatibility antigen like ALFPGVALL.  Additionally, cathepsin G is a 
protein, like neutrophil elastase, that is produced in primary granules in myeloid 
hematopoietic tissue, and as such, is expressed primarily in the bone marrow 
potentially making it a good target for leukemia based immunotherapy. 
5.4 Conclusions 
Affinity chromatography and liquid chromatography coupled to mass 
spectrometry and database searching are effective in identifying HLA-A*201 
presented peptides on leukemia. Eighteen peptides predicted to be tight binders 
have been identified. Peptides are nine amino acid residues in length and have 
leucine in position two and valine, leucine or alanine in postion nine. Several of 
the identified peptides have properties that may make them candidate anti-
cancer immune targets.   
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Chapter 6
Conclusions and Future Directions 
 
6.1 Summary 
In the work presented here, quadrupole ion trap tandem mass 
spectrometry has been used for both fundamental and applied study of 
biomolecules. It has been shown that iTRAQ quantification using a QITMS can 
be achieved using thermally assisted collision induced dissociation (TA-CID), 
high amplitude short time excitation (HASTE) CID, infrared multiphoton 
dissociation (IRMPD), and thermally assisted IRMPD (TA-IRMPD).  Electron 
capture dissociation (ECD) was used for quality validation of large recombinant 
proteins for X-ray crystallography and screening purposes. Furthermore, a new 
method, electron ionization dissociation (EID) was developed for proteomics. The 
fundamental aspects and analytical applications of EID were studied. Finally, 
collision induced dissociation was used to identify class I major histocompatibility 
complex (MHC I) presented peptides on leukemia for anti-cancer immune 
therapy.  
6.2 iTRAQ Quantification using a QITMS 
Stable isotope labeling is a common approach to quantitative MS 
proteomics. Isobaric tag for relative and absolute quantification (iTRAQ) is one of 
the most common stable isotope labeling methods and is based on the covalent 
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linkage of primary amines with tags of varying masses. Quantitative information 
using iTRAQ is obtained from the abundance of low mass reporter ions, m/z 114-
117 for a 4-plex reagent, observed in MS/MS spectra. CID is the most commonly 
used ion activation method in MS/MS. However, conventional CID in a QITMS 
cannot trap product ions below a low-mass cut-off (LMCO) of ~ 25% of the parent 
ion mass-to-charge, thus iTRAQ reporter ions are usually not detected.  
It was shown that detection of the reporter ions can be accomplished 
using TA-CID, HASTECID, IRMPD, and TA IRMPD, which allow the  LMCO to be 
reduced to ~10% of the parent ion mass-to-charge. The methods were compared 
based on MS/MS efficiency, which is the ratio of summed product ion abundance 
to the initial parent ion abundance before activation, and conversion efficiency 
which measures the effectiveness of a method to generate the iTRAQ reporter 
ions. As a proof of principal experiment, iTRAQ 114 and 117 labeled peptide 
were mixed at ratios varying from 1:1 to 1:10 for relative quantification.   
The IRMPD methods gave the highest MS/MS efficiency and HASTE CID 
gave the worst. The poor MS/MS efficiency observed in HASTE CID can be 
attributed to the high amplitude excitation voltages used which may cause ion 
motion to exceed the boundaries of the trapping field therefore, causing their 
ejection. In terms of conversion efficiency, the IRMPD methods were also better 
than the CID methods. Focused laser IRMPD produced much more abundant 
reporter ions as compared to the other methods, consequently, accurate and 
precise quantification was observed at all concentration ratios studied. However, 
product ion abundances due to peptide backbone cleavages were lower with the 
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IRMPD methods as compared to TA-CID and HASTE CID. The low backbone 
cleavage ion abundance imply that sequence ions cannot be confidently 
assigned which results in a lower sequence coverage relative to the CID 
methods. The work in this chapter was a fundamental study. In the future, an 
application of the studied MS/MS methods for protein identification and 
quantification is necessarily to further determine the effectiveness of the 
methods. 
6.3 ECD of Recombinant Proteins in a Radiofrequency Ion Trap 
Prior to 2004, ECD could only be performed using Fourier transform ion 
cyclotron resonance (FT-ICR) mass spectrometer. In 2004, Baba et. al. reported 
on the successful implementation of ECD in a radiofrequency ion trap1 which 
brought the benefits of ECD to the more commonly used instrument. 
 Analysis of recombinant proteins is critical for quality control of protein 
therapeutics. Establishing the integrity of the protein and verifying its sequence is 
done by mass spectrometry.  Protein sequencing is performed using the bottom 
up approach where the protein sample undergoes proteolysis for 4 – 18 hours to 
form peptides prior to LC/MS/MS analysis. Alternatively, in the top down 
approach intact proteins are ionized, dissociated, and mass analyzed without a 
proteolysis step. ECD often provides extensive backbone fragmentation while 
preserving post translational modifications (PTMs) which makes it the method of 
choice for top down proteomics. 
Recombinant Farnesoid X Receptor (FXR), Retinoic Acid Receptor (RAR) 
- Related Orphan Receptor (ROR) βeta, and epidermal growth factor receptor 
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(EGFR) were studied. FXR is a ligand - regulated nuclear receptors and serves 
as a bile acid sensor in the liver.2 ROR-β is also a nuclear receptor. It is highly 
expressed in neonatal cells and is thought to play a role in the development of 
rod photoreceptors.3 In the analysis of FXR, no modification was detected. In the 
case of ROR-β, a 12 Da modification was detected but the identity could not be 
determined. ECD gave extensive sequence coverage of the N-terminal part of 
the protein only. It is possible that the modification occurred away from the N-
terminus which precludes its identification from the data. Finally, EGFR is a well 
characterized oncology target for breast cancer. ECD of EGFR, MW 40.5 kDa 
produced a series of N-terminal ions from which a 42 Da mass shift from the 
theoretical mass was detected. The 42 Da post translational modification could 
be assigned as acetylation of the protein’s N-terminus or lysine amino acid 
residue. 
 Some future works include identification of the 12 Da modification 
observed for ROR-β, performing ECD on liquid chromatography timescale and 
improving the sensitivity of the experiment. To determine the cause of the ROR-β 
modification, a bottom-up approach would be necessary. Offline ECD of 
fractionated recombinant proteins was used for the reported experiments. 
Attempt at performing ECD on LC-time scale was not successful due to low 
protein signal. The low abundance was primarily due to the multiple charging of 
electrospray ionization because protein signal is distributed into many charge 
states. One way to overcome this issue is to perform ion molecule reaction to 
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concentrate different charge states into one peak. Ion parking4 could also be 
used to overcome the multiple charging issue. 
6.4 EID in a Radiofrequency Linear Ion Trap 
In EID, singly and multiply charged cations are reacted with high kinetic 
energy electrons, at least 10 eV above the ionization potential, to form an 
oxidized species which dissociates to form product ions. To date, EID has only 
been reported using FTICR MS. In this work, an ion trap mass spectrometer is 
used which allows unique opportunities, such as MSn capability, to study the EID 
process that is not readily feasible using an FT-ICR instrument.  
6.4.1 Fundamentals 
It was determined that the efficiency of ion electron interaction was optimum 
at 30 eV using doubly charged substance P therefore 30 eV was used for the 
work in this chapter. However, it was found that product ions were most 
abundant at 20 eV for [FLEEV+H]+, in an experiment where spectra were taken 
at different electron energies. Few new product ions with very low abundances 
were observed above 20 eV which further suggests that 20 eV could be more 
appropriate for performing EID of singly charged peptides. In the future, MS/MS 
efficiency experiments are needed to determine the optimum electron energy. 
In terms of spectral content, EID spectra are different from that of ECD and 
CID. In ECD, the parent ion captures an electron to form a charge reduced 
radical ion which dissociates to form c′ and z• ions. In CID, the fragmenting ion 
has an even number of electrons and dissociates to form b and y product ions.  
In EID, there are many fragmenting species, the even electron parent ion, the 
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oxidized species produced from ionization, and the charge reduced species 
formed from capture of low energy electron. It was determined that the low 
energy electrons were mostly from ionization of the bath gas. In the future it is 
important to compare fragmentation of the charge reduced species observed in 
EID to that observed in ECD.  
 In the case of [melittin+3H]3+, a doubly oxidized species was observed. The 
ion was found to originate from ejection of an electron from the singly oxidized 
species. All of the mentioned ions of the molecular species can dissociate to form 
product ions, therefore all backbone cleavage ion types, a/x, b/y and c′/z• are 
often observed. Consequently, the products ions in EID are many and often 
result in a higher sequence coverage as compared to ECD and CID. Additionally, 
neutral losses of amino acid side chains from the oxidized species are often 
observed and can be used, like immonium ions, to indicate the presence of 
specific amino acids.  
In EID spectra, the oxidized species is often present at a high abundance 
relative to backbone cleavage ions. An abundance oxidized species can be used 
to determine the oxidation threshold (essentially the ionization energy) of ions. 
However, the abundance of the oxidized species is uninformative for sequencing 
purposes. In ECD, the charge reduced species (due to non-dissociative electron 
capture) is also often dominant relative to backbone cleavage ions. The non-
dissociative electron capture is due to intact noncovalent interactions that prevent 
product ion separation after backbone cleavage. Collisions with bath gas, IR 
irradiation, or heat have been used to activate the charge reduced species so 
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that the non covalent interactions are disrupted and product ions are observed. 
This method termed activated ion (AI) ECD is commonly used to improve 
sequence coverage and product ion abundance in ECD.5, 6 To mimic such an 
experiment, collisional activation of the oxidized species was performed 
simultaneously with electron irradiation (EID+CID). No significant increase in 
product ion abundance or sequence coverage was obtained.  
The result of the EID+CID experiments, confirmed that all product ions in 
EID spectra do not originate from the oxidized species. The results also suggests 
that intramolecular interactions may be lost upon ionization in which case 
supplemental activation would have no effect on product ion observation. 
Another reason for the observed difference in activation of the oxidized species 
vs. activation of the charge reduced species was attributed to the nature of the 
radical ions. The species formed upon electron capture is hydrogen abundant, 
i.e. it has an extra hydrogen atom relative to the charge. Conversely, the species 
formed upon interaction with high energy electron is hydrogen deficient i.e. it 
lacks a hydrogen atom relative to the fully protonated, even electron ion. 
ECD/CID MS3 of the charge reduced radical cation and EID/CID MS3 of the 
oxidized radical cation were found to be different.  
Finally, the presence of c′ ions in EID spectra of singly charged peptides 
was unexpected. The prime indicates that the product ion is one Da heavier than 
expected from homolytic cleavage of the N-Cα bond. Such an ion is formed in 
ECD from charge neutralization upon electron capture. Such a process is not 
expected in the case of singly protonated peptides because electron capture 
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would result in a neutral which is not detected in mass spectrometry. Therefore, 
intramolecular hydrogen transfer from the N-terminal side is necessary to explain 
c′ ion formation in EID. 
 Future studies include: identification of the origin of the13 Da loss ion (m/z 
445.57) from the oxidized species of [substance P+2H]3+•. Also, the origin of an 
ion at m/z 205.1 in the EID spectra of [YGAFL+H]+ is not known. One possibility, 
that needs to be studied, is rearrangement of the amino acid residues to YAGFL 
followed by cleavage of the N and C terminal moieties to form the internal 
fragment, GF which matches the observed mass-to-charge value. Another future 
study concerns the [bn-1+H2O] product observed in the EID/CID MS
3 experiment 
of [substance P+2H]2+. Because the ion is formed from loss of the C-terminal 
amino acid residue, C terminal peptide sequencing could be achieved.  
6.4.2 Applications 
6.4.2.1 N/C Terminal Differentiation in de novo Sequencing 
Tandem mass spectrometry data is generally searched against a genomic 
or protein database search for protein identification. In the case of an organism 
whose genome has not been sequenced and therefore not known, de novo 
sequencing is required. A major part of de novo sequencing pertains to 
distinguishing the N- and C terminal ends of a peptide. An approach which takes 
advantage of the fact that EID gives all product ion types, is detailed. The 
difference in mass between a and b ions is 28 Da, and the difference in mass 
between c′ and b ions is 17 Da. Conversely 26 Da separates x and y ions and 16 
Da is the difference in mass between y and z• ions. Starting at a given peak a 28 
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Da mass difference followed by a 17 Da mass difference would be indicative of 
an N-terminal product.  A 26 Da followed by a 16 Da mass difference would 
indicate a C-terminal product ion.The approach detailed above needs to be 
applied to a large data set and combined with bioinformatics to determine the 
feasibility of the method and the rate of false positives. The large data set would 
be generated from cell lysis followed by two-dimensional LC EID MS.  
6.4.2.2 Analysis of Phosphorylated  Peptides 
Protein phosphorylation is one of the most common post translational 
modifications (PTMs) in eukaryotes and plays a significant role in cell signaling. 
CID, of phosphopeptides often generally results in loss of the phosphoric acid 
moiety. ECD is known to preserve PTMs upon backbone cleavage which allows 
localization of the modified site. The applicability of EID for analysis of 
phosphorylated peptides was studied and compared to CID and ECD.  
Loss of phosphoric acid from the parent ion was the dominant 
fragmentation channel in CID of singly protonated peptides. Hence backbone 
cleavage ions were observed at a relatively low abundance which does not allow 
for confident assignment of ions. However, the modification was retained to the 
extent that localization of the modified residue was possible. In the case of EID, 
virtually no loss of phosphoric acid from the parent ion or the oxidized species 
was observed. Therefore abundant backbone cleavage ions were observed 
which allowed for confident assignment of the phosphorylated residue.  
EID was also compared to both ECD and CID for the analysis of multiply 
charged peptides. In some cases, ECD did not give sufficient backbone cleavage 
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to determine the modified amino acid residue(s) while EID and CID often did. The 
results show that backbone cleavage is equally as important as retention of the 
modification in localization of phosphorylated residues. In terms of sequence 
coverage EID was often superior to both ECD and CID. Because EID gives high 
sequence coverage and also retains the modification, it is a viable alternative to 
ECD and CID in analysis of phosphorylated peptides. 
6.4.2.3 Analysis of Sodiated Ions 
6.4.2.3.1 Peptides 
CID of protonated peptides typically results in product ion formation from 
both the N and C terminus which can complicate spectral interpretation. 
Conversely, sodium cationized peptides fragment by loss of the C-terminal 
residue to form product ion that is an amino acid shorter than the original 
peptide7 and has been used for C-terminal sequencing.8 The dissociation pattern 
of sodiated peptides using EID was studied and compared to that of CID. For 
small sodiated peptides EID was found to be more informative than CID because 
side chain losses were observed in addition to loss of the C-terminal amino acid 
residue.  However, EID of larger peptides resulted in both N and C terminal 
product ions, which is not beneficial for C-terminal sequencing. 
6.4.2.3.2 Oligosacharides 
Glycosylation, the attachment of oligosaccharides, is the most common 
post translational modification in eukaryotic proteins. Oligosaccharides consist of 
short chains of simple sugars joined by a glycosidic bond. There are at least 
eight common sugar mononers and multiple linkage types which makes analysis 
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of glycosylated proteins challenging. CID of maltotetraose, a tetrasacharide with 
four glucose monomers in a [glucosyl(α1→4)glucose] linkage was dominated by 
glycosidic bond cleavage ions. The glycosidic bond cleavage ions indicate the 
number of monomer units but give no information about the glycan structure. The 
EID spectrum, however, contained a variety of abundant cross ring cleavage 
product ions which are essential for determining monomer to monomer linkage 
type. 
6.5 Identification and Characterization of Class I MHC Presented 
Peptides on Leukemia  
This chapter is a real world application of tandem mass spectrometry. 
Peptides presented by the HLA-A*0201 molecules on leukemia cells were 
identified and characterized using MS/MS and database searching.  The HLA 
presented peptides are known to be 8-10 residues in length, therefore 
electrospray ionization produces singly and doubly charged peptides which are 
not optimal for ECD. EID, although appropriate for analytes with low charge 
state, gives many product ions which could increase the rate of false positive 
identifications using database searching. Additionally, EID of singly charged 
peptides of the specified length produces a/x type ions predominantly which are 
not considered in current database search algorithms. Because of these reasons, 
CID was the method used. 
Affinity chromatography and liquid chromatography coupled to tandem 
mass spectrometry and database searching were used to identifying HLA-A*201 
presented peptides on leukemia. Eighteen peptides predicted in silico to be tight 
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binders were identified. Peptides were nine amino acid residues in length had 
leucine in position two and valine, leucine or alanine in position nine. Several of 
the identified peptides had properties that could make them candidate anti-
cancer immune targets.   
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